var title_f15_44_16064="Hydrosalpinx 3D";
var content_f15_44_16064=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F65022&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F65022&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Hydrosalpinx",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 216px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transvaginal ultrasound image of the adnexa showing a",
"    <br>",
"     hydrosalpinx with three-dimensional rendering. A cystic structure",
"     <br>",
"      with a septation (arrow) is identified in the adnexa. The rendered image (on right side of illustration) demonstrates a tubular fluid collection with incomplete septations indicating a serpiginously dilated fallopian tube.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced with permission from: Thomas D Shipp, MD. Copyright &copy; Thomas D Shipp, MD.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16064=[""].join("\n");
var outline_f15_44_16064=null;
var title_f15_44_16065="Head lice";
var content_f15_44_16065=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Head lice (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?15/44/16065/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16065/contributors\" id=\"au5345\">",
"       Adam O Goldstein, MD, MPH",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16065/contributors\" id=\"au5343\">",
"       Beth G Goldstein, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?15/44/16065/contributors\">",
"       Section Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16065/contributors\" id=\"se7157\">",
"       Robert P Dellavalle, MD, PhD, MSPH",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16065/contributors\" id=\"se4893\">",
"       Moise L Levy, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?15/44/16065/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16065/contributors\" id=\"de2840\">",
"       Abena O Ofori, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?15/44/16065?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     There are three types of lice that infest humans (",
"     <a class=\"graphic graphic_figure graphicRef67309 \" href=\"UTD.htm?2/40/2690\">",
"      figure 1",
"     </a>",
"     ):",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The head louse",
"      </li>",
"      <li>",
"       The body louse",
"      </li>",
"      <li>",
"       The pubic louse or \"crab\"",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Head lice are usually spread from one person to another through casual contact. Although head lice can be unpleasant, there are effective treatment options available. It is important to find and treat lice quickly to avoid spreading them to others.",
"    </p>",
"    <p>",
"     This article discusses the diagnosis and treatment of head lice. Pubic lice are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/12/27843?source=see_link\">",
"      \"Patient information: Pubic lice (Beyond the Basics)\"",
"     </a>",
"     .) A more detailed discussion of head lice is available by subscription. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/15/25849?source=see_link\">",
"      \"Pediculosis capitis\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      HEAD LICE DESCRIPTION",
"     </span>",
"    </p>",
"    <p>",
"     The head louse is a tiny, grayish-white insect. Female head lice typically live for about one month and lay 7 to 10 eggs (called nits) per day. The eggs are attached to the base of a hair, near the scalp. The eggs hatch after about eight days.",
"    </p>",
"    <p>",
"     After the eggs hatch, the egg cases become easier to see. Since the eggs are firmly attached to the hair, they move away from the scalp as the hair grows. Head lice do not jump or fly, and they cannot spread from person to person by attaching to pets.",
"    </p>",
"    <p>",
"     Head lice often affect children. In one study, approximately one of every four elementary-level students in the United States had head lice [",
"     <a class=\"abstract\" href=\"UTD.htm?15/44/16065/abstract/1,2\">",
"      1,2",
"     </a>",
"     ]. This is because lice are easily spread:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       When children play together",
"      </li>",
"      <li>",
"       From articles of clothing on adjacent hooks in classrooms",
"      </li>",
"      <li>",
"       On shared combs, headphones, towels, and beds",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Black children are affected much less frequently than whites and others, and males less than females; the reasons for this are not known.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      HEAD LICE SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Most people with head lice do not have any symptoms. Some people feel itching or skin irritation of the scalp, neck, and ears. This is caused by a reaction to lice saliva, which the lice inject into the skin during feeding.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      HEAD LICE DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Head lice are diagnosed by examination of the scalp and hair (",
"     <a class=\"graphic graphic_picture graphicRef79421 \" href=\"UTD.htm?21/7/21621\">",
"      picture 1",
"     </a>",
"     ). Special \"nit combs\" can be used to assist with the diagnosis.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Before using the fine-toothed comb, use a regular brush or comb to remove tangles. This can be done while the hair is wet or dry. If the hair is wet, apply hair conditioner to make the hair easier to comb.",
"      </li>",
"      <li>",
"       Place the fine-toothed comb at the top of the head, touching the scalp. Pull the comb through the hair from roots to ends. After each stroke, carefully examine the comb for lice or eggs.",
"      </li>",
"      <li>",
"       Comb the entire head at least twice",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Finding eggs (nits) without lice does not necessarily mean that there is an active infestation; nits can be found for months after lice are treated. Because lice lay eggs at the base of the hair shaft, the identification of nits within &frac14; inch of the scalp suggests (but does not confirm) an active infestation [",
"     <a class=\"abstract\" href=\"UTD.htm?15/44/16065/abstract/3\">",
"      3",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     Lice can be more difficult to see than nits since they can move and hide from view. A doctor or nurse can examine the head under a special lamp, which causes nits to glow a pale blue color. If you are unsure whether your child has lice, make an appointment for your child to be examined before you start treatment.",
"    </p>",
"    <p>",
"     Finding head lice can be upsetting to children and parents, but it is important to keep the following in mind:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Lice are not a sign of being dirty or sick",
"      </li>",
"      <li>",
"       You can get rid of lice with proper treatment",
"      </li>",
"      <li>",
"       There are no serious or long-term health problems associated with lice",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      HEAD LICE TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     There are several options for getting rid of head lice, including creams and liquids, combing, and oral medicines (pills). It is important to follow directions carefully to be sure that the treatment works.",
"    </p>",
"    <p>",
"     If you are sure that your child (over age two years) has head lice, you can use a nonprescription lice treatment (see",
"     <a class=\"local\" href=\"#H6\">",
"      'Insecticides'",
"     </a>",
"     below). Examine family members and close contacts at the same time and treat them if needed. If your child is under age two years, contact the child's doctor or nurse for treatment advice.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Insecticides",
"     </span>",
"     &nbsp;&mdash;&nbsp;A topical insecticide (pediculicide) is a substance, usually a lotion or gel, that is applied to the scalp to kill lice. Available insecticides include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Permethrin (Nix&reg;, Rid&reg;)",
"      </li>",
"      <li>",
"       Pyrethrin (A-200&reg;, Pronto&reg;, Tisit&reg;)",
"      </li>",
"      <li>",
"       Malathion (Ovide&reg;, prescription required in the United States)",
"      </li>",
"      <li>",
"       Benzyl alcohol (Ulesfia&reg;, prescription required)",
"      </li>",
"      <li>",
"       Spinosad (Natroba&reg;, prescription required)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Follow the manufacturer's instructions for applying the insecticide carefully. Typically, you wash the hair with shampoo, rinse it, and towel-dry it. Apply the insecticide cream or gel liberally to the scalp and leave on for 10 minutes before rinsing with water. Malathion (Ovide&reg;) should be left on the scalp for 8 to 12 hours or overnight. Malathion has a bad smell, which can be hard for some people to tolerate.",
"    </p>",
"    <p>",
"     A second treatment is needed with permethrin, pyrethrin, and benzyl alcohol 7 to 10 days after the first treatment. This is because some lice are able to survive the first treatment. A single application of malathion often is sufficient. However, malathion should be reapplied if live lice are seen seven to nine days after treatment. Treatment with spinosad should be repeated if live lice remain after seven days.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Wet-combing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Wet-combing is a way to remove lice from the hair with careful and repeated combing. It is a good option for treating very young children or if you want to avoid using insecticides. However, wet-combing is time consuming and must be repeated multiple times over a period of a few weeks.",
"    </p>",
"    <p>",
"     Wet the hair and add a lubricant, such as hair conditioner or cream rinse, vinegar, or olive oil. See above for a description of how to wet-comb. (See",
"     <a class=\"local\" href=\"#H4\">",
"      'Head lice diagnosis'",
"     </a>",
"     above.) The combing session should take 15 to 30 minutes, depending how long and thick the hair is. Comb every three to four days for two weeks AFTER you find any large, adult lice.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Oral medicines",
"     </span>",
"     &nbsp;&mdash;&nbsp;Oral medicines (a pill) might be prescribed for people whose lice are resistant to insecticide treatment.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Other treatments",
"     </span>",
"     &nbsp;&mdash;&nbsp;Studies have examined lotions and other materials (olive oil, butter, mayonnaise, petroleum jelly (Vaseline&reg;)) that are applied to the head, and then allowed to dry, with the goal of suffocating lice. However, lice are difficult to suffocate; wet-combing probably works as well and is less messy.",
"    </p>",
"    <p>",
"     Lice treatments that use gasoline or kerosine are toxic and can lead to serious injury and should not be used.",
"    </p>",
"    <p>",
"     We do not recommend any of these \"natural\" treatments.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      PREVENTING HEAD LICE SPREAD",
"     </span>",
"    </p>",
"    <p>",
"     Adults and children who live with a person diagnosed with lice should be examined for lice and treated if needed. Anyone who sleeps in the same bed should be treated for lice, even if no lice or eggs are found.",
"    </p>",
"    <p>",
"     School policies differ about who at a school, if anyone, needs to be informed when a child has lice. A confidential call or visit with the school nurse is a good place to start. Some schools have a \"no nits\" policy that prevents a child from returning until no nits are found. However, most experts believe that children can return to school after one treatment with insecticide or the first wet-combing session.",
"    </p>",
"    <p>",
"     Clothing, bedding, and towels used within 48 hours before treatment should be washed in hot water and dried in an electric dryer on the hot setting. Dry cleaning is also effective. You can use a vacuum to clean furniture, carpet, and car seats. Items that cannot be washed or vacuumed can be sealed inside a plastic bag for two weeks. Items that the person used more than two days before treatment are not likely to be infested because head lice cannot survive off the body for more than 48 hours.",
"    </p>",
"    <p>",
"     You do not need to have your home sprayed for lice. Routine cleaning and vacuuming is all that is needed to remove lice.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1784903443\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15026455\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/5/43089?source=see_link\">",
"      Patient information: Lice (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15026470\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/12/27843?source=see_link\">",
"      Patient information: Pubic lice (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/28/37318?source=see_link\">",
"      Approach to the patient with a scalp eruption",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/15/25849?source=see_link\">",
"      Pediculosis capitis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24339?source=see_link\">",
"      Pediculosis corporis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1511?source=see_link\">",
"      Pediculosis pubis and pediculosis ciliaris",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/headlice.html\">",
"      www.nlm.nih.gov/medlineplus/headlice.html",
"     </a>",
"     , available in Spanish)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Center for Disease Control and Prevention",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/lice/\">",
"      www.cdc.gov/lice/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The Nemours Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://kidshealth.org/parent/infections/common/lice.html\">",
"      file://kidshealth.org/parent/infections/common/lice.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     UpToDate wishes to acknowledge Kelly Crowley for her contributions to this topic.",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?15/44/16065/abstract/1,2,4,5\">",
"      1,2,4,5",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 18, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?15/44/16065?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16065/abstract/1\">",
"      Price JH, Burkhart CN, Burkhart CG, Islam R. School nurses' perceptions of and experiences with head lice. J Sch Health 1999; 69:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16065/abstract/2\">",
"      A modern scourge: parents scratch their heads over lice. Consum Rep 1998; 63:62.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/lice/head/index.html (Accessed on September 21, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16065/abstract/4\">",
"      Dodd CS. Interventions for treating headlice. Cochrane Database Syst Rev 2001; :CD001165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16065/abstract/5\">",
"      Lebwohl M, Clark L, Levitt J. Therapy for head lice based on life cycle, resistance, and safety considerations. Pediatrics 2007; 119:965.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f15_44_16065=[""].join("\n");
var outline_f15_44_16065=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           HEAD LICE DESCRIPTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           HEAD LICE SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           HEAD LICE DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           HEAD LICE TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           PREVENTING HEAD LICE SPREAD",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/40/2690\" title=\"figure 1\">",
"           Types of lice PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/7/21621\" title=\"picture 1\">",
"           Head lice nits PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f15_44_16066="Torsion of fallopian tube";
var content_f15_44_16066=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F82480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F82480&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Tubal torsion demonstrating severe distension of the distal tube",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 356px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pediatric&nbsp;and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR, Goldstein DP (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16066=[""].join("\n");
var outline_f15_44_16066=null;
var title_f15_44_16067="Ear wax impaction PI";
var content_f15_44_16067=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F74771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F74771&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Ear wax impaction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 410px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This drawing shows where ear wax can build up (become impacted) in the ear canal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16067=[""].join("\n");
var outline_f15_44_16067=null;
var title_f15_44_16068="Zanamivir: Patient drug information";
var content_f15_44_16068=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Zanamivir: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/27/26038?source=see_link\">",
"     see \"Zanamivir: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/47/16117?source=see_link\">",
"     see \"Zanamivir: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F235668\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Relenza&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F235669\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Relenza&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022800\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691530",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat the flu.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703141",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to zanamivir or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701034",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to milk, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697688",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is not to be taken in place of a flu shot. If your doctor told you to get the flu shot, you need to get it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697301",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. This drug is not often used in patients with these diseases.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698256",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose and throat irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698350",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sore throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022807\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699005",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad problems with how you act.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022802\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694896",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For breathing in only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Start this drug as soon as you can.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695877",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take in the morning and evening for 5 days.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695926",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 2 doses on the first day of care if you can. Space the doses by at least 2 hours that first day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022808\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11151 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-C3286EAA3D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16068=[""].join("\n");
var outline_f15_44_16068=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235668\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235669\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022800\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022799\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022804\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022805\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022807\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022802\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022803\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022808\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022809\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?25/27/26038?source=related_link\">",
"      Zanamivir: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/47/16117?source=related_link\">",
"      Zanamivir: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_44_16069="Ureter and blood vessels";
var content_f15_44_16069=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F64999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F64999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 477px\">",
"   <div class=\"ttl\">",
"    Identification of the ureter and superior vesical artery during hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 457px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The peritoneal reflection anterior to the uterus is incised and the bladder reflected inferiorly with sharp dissection. The ureter is identified on the medial aspect of the broad ligament during the development of the perivesical and perirectal spaces, as is the superior vesical artery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16069=[""].join("\n");
var outline_f15_44_16069=null;
var title_f15_44_16070="Cefixime: Drug information";
var content_f15_44_16070=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cefixime: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?9/38/9828?source=see_link\">",
"    see \"Cefixime: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/32/38404?source=see_link\">",
"    see \"Cefixime: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F147405\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Suprax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F147406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Suprax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F147443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Cephalosporin (Third Generation)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F147409\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Susceptible infections:",
"     </b>",
"     Oral: 400 mg/day divided every 12-24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Gonococcal infection, uncomplicated cervical/urethral/rectal gonorrhea due to",
"     </b>",
"     <b>",
"      <i>",
"       N. gonorrhoeae:",
"      </i>",
"     </b>",
"     Oral: 400 mg as a single dose in combination with oral azithromycin (preferred) or oral doxycycline (CDC, 2010).",
"     <b>",
"      Note:",
"     </b>",
"     CDC no longer recommends cefixime as a first-line agent (ceftriaxone is the preferred cephalosporin), if cefixime is used  as an alternative agent,  test-of-cure follow up in 7 days is recommended; in addition, cefixime is",
"     <b>",
"      not",
"     </b>",
"     an option for the treatment of uncomplicated gonorrhea of the pharynx (CDC, 2012). In Canada, due to increased antimicrobial resistance, the Public Health Agency of Canada recommends 800 mg as a single dose (unlabeled dose) for treatment of uncomplicated gonococcal infections.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Gonococcal infection, expedited partner therapy:",
"     </b>",
"     Oral: 400 mg as a single dose in combination with oral azithromycin (CDC, 2012).",
"     <b>",
"      Note:",
"     </b>",
"     Only used if a heterosexual partner cannot be linked to evaluation and treatment in a timely manner; dose delivered to partner by patient, collaborating pharmacy, or disease investigation specialist.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       S. pyogenes",
"      </i>",
"     </b>",
"     <b>",
"      infections:",
"     </b>",
"     Oral: 400 mg/day divided every 12-24 hours for 10 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Typhoid fever (unlabeled use):",
"     </b>",
"     Oral: 20-30 mg/kg/day in 2 divided doses for 7-14 days after I.V. therapy",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F147427\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/32/38404?source=see_link\">",
"      see \"Cefixime: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Susceptible infections:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;6 months: 8 mg/kg/day divided every 12-24 hours (maximum:  400 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &gt;50 kg or &gt;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Acute bacterial rhinosinusitis (unlabeled use):",
"     </b>",
"     Oral: 8 mg/kg/day divided every 12 hours with concomitant clindamycin for 10-14 days.",
"     <b>",
"      Note:",
"     </b>",
"     Recommended in patients with non-type I penicillin allergy, after failure of initial therapy or in patients at risk for antibiotic resistance (eg, daycare attendance, age &lt;2 years, recent hospitalization, antibiotic use within the past month) (Chow, 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Gonococcal infection, uncomplicated:",
"     </b>",
"     Oral: Children &gt;45 kg: 400 mg as a single dose in combination with oral azithromycin (preferred) or oral doxycycline (CDC, 2010).",
"     <b>",
"      Note:",
"     </b>",
"     CDC no longer recommends cefixime as a first-line agent, only use as an alternative agent with test-of-cure follow up in 7 days (CDC, 2012). In Canada, due to increased antimicrobial resistance, the Public Health Agency of Canada recommends 800 mg as a single dose (unlabeled dose) for treatment of uncomplicated gonococcal infections in children &ge;9 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       S. pyogenes",
"      </i>",
"     </b>",
"     <b>",
"      infections:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &ge;6 months: 8 mg/kg/day divided every 12-24 hours for 10 days (maximum: 400 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children &gt;50 kg or &gt;12 years: 400 mg/day divided every 12-24 hours for 10 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Typhoid fever (unlabeled use):",
"     </b>",
"     Oral: 20 mg/kg/day for 10-14 days; maximum 400 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F147410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F147411\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;60 mL/minute: No dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     21-60 mL/minute: 260 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;20 mL/minute: 200 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     CAPD: 200 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Intermittent hemodialysis: Not significantly removed.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F147381\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral, as trihydrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Suprax&reg;: 400 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for suspension, oral, as trihydrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Suprax&reg;: 100 mg/5 mL (50 mL, 100 mL [DSC]); 200 mg/5 mL (50 mL, 75 mL) [contains sodium benzoate; strawberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as trihydrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Suprax&reg;: 400 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, chewable, oral, as trihydrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Suprax&reg;: 100 mg [contains phenylalanine 3.3 mg/tablet; tutti frutti flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Suprax&reg;: 200 mg [contains phenylalanine 6.7 mg/tablet; tutti frutti flavor]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F147365\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F147385\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered with or without food; administer with food to decrease GI distress. Shake oral suspension well before use.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F147384\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of urinary tract infections, otitis media, respiratory infections due to susceptible organisms including",
"     <i>",
"      S. pneumoniae",
"     </i>",
"     and",
"     <i>",
"      S. pyogenes",
"     </i>",
"     ,",
"     <i>",
"      H. influenzae",
"     </i>",
"     , and many Enterobacteriaceae; uncomplicated cervical/urethral gonorrhea due to",
"     <i>",
"      N. gonorrhoeae",
"     </i>",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Due to concerns of resistance, the CDC no longer recommends use of cefixime as a first-line regimen in the treatment of uncomplicated gonorrhea in the U.S.; ceftriaxone is the preferred cephalosporin (CDC, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F14470550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acute bacterial rhinosinusitis (ABRS) (pediatric) in combination with clindamycin",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F147450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Cefixime may be confused with cefepime",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Suprax&reg; may be confused with Sporanox&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Cefiton: Brand name for cefixime [Portugal] may be confused with Ceftim brand name for ceftazidime [Portugal]; Ceftime brand name for ceftazidime [Thailand]; Ceftin brand name for cefuroxime [U.S., Canada]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F147441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Gastrointestinal: Diarrhea (16%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     2% to 10%: Gastrointestinal: Abdominal pain, nausea, dyspepsia, flatulence, loose stools",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;2% (Limited to important or life-threatening): Acute renal failure, anaphylactic/anaphylactoid reactions, angioedema, BUN increased, candidiasis, creatinine increased, dizziness, drug fever, eosinophilia, erythema multiforme, facial edema, fever, headache, hepatitis, hyperbilirubinemia, jaundice, leukopenia, neutropenia, pruritus, pseudomembranous colitis,  PT prolonged, rash, seizure, serum sickness-like reaction, Stevens-Johnson syndrome, thrombocytopenia, toxic epidermal necrolysis, transaminases increased, urticaria, vaginitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Reactions reported with other cephalosporins: Agranulocytosis, aplastic anemia, colitis, hemolytic anemia, hemorrhage, interstitial nephritis, pancytopenia, superinfection",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F147388\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to cefixime, any component of the formulation, or other cephalosporins",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F147369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Penicillin allergy: Use with caution in patients with a history of penicillin allergy, especially IgE-mediated reactions (eg, anaphylaxis, angioedema, urticaria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; modify dosage.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F147374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: Cephalosporins (3rd Generation) may enhance the nephrotoxic effect of Aminoglycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Cephalosporins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Cephalosporins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F147401\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: Delays cefixime absorption.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F147377\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5951284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal reproduction studies. Cefixime crosses the placenta and can be detected in the amniotic fluid. An increase in most types of birth defects was not found following first trimester exposure to cephalosporins. Cefixime may be used for the treatment of gonococcal infections in pregnant women in certain situations (refer to current guidelines).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F147415\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F147391\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if cefixime is excreted in breast milk. The manufacturer recommends that consideration be given to discontinuing nursing temporarily during treatment. If present in breast milk, nondose-related effects could include modification of bowel flora.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F147392\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with food to decrease GI distress.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F6133204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chewable",
"     </b>",
"     (Suprax Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (10): $162.64",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg (10): $325.25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension (reconstituted)",
"     </b>",
"     (Suprax Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg/5 mL (50 mL): $162.64",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg/5 mL (50 mL): $325.25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Suprax Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     400 mg (50): $960.47",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F147379\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     With prolonged therapy, monitor renal and hepatic function periodically. Observe for signs and symptoms of anaphylaxis during first dose. When used as part of alternative treatment for gonococcal infection, test-of-cure 7 days after dose (CDC, 2012).",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F147393\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aerocef (AT);",
"     </li>",
"     <li>",
"      Anfix (ID);",
"     </li>",
"     <li>",
"      Axetef (PH);",
"     </li>",
"     <li>",
"      Cefarox (ID);",
"     </li>",
"     <li>",
"      Cefirax (KP);",
"     </li>",
"     <li>",
"      Cefix (AE, BH, BR, CY, EG, IQ, IR, JO, KP, KW, LB, LY, MY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Cefixmycin (PH, TW);",
"     </li>",
"     <li>",
"      Cefspan (CL, CN, ID, JP, PK, TH);",
"     </li>",
"     <li>",
"      Ceftoral (GR);",
"     </li>",
"     <li>",
"      Cephoral (CH, DE, PL);",
"     </li>",
"     <li>",
"      Cexim (TW);",
"     </li>",
"     <li>",
"      Cexima (PY);",
"     </li>",
"     <li>",
"      Cifacure (PH);",
"     </li>",
"     <li>",
"      Denvar (CR, DO, ES, GT, HN, MX, NI, PA, SV);",
"     </li>",
"     <li>",
"      Devoxim (CO);",
"     </li>",
"     <li>",
"      Fix-A (PH);",
"     </li>",
"     <li>",
"      Fixcef (PH);",
"     </li>",
"     <li>",
"      Fixef (ID);",
"     </li>",
"     <li>",
"      Fixim (NL);",
"     </li>",
"     <li>",
"      Fixime (ZA);",
"     </li>",
"     <li>",
"      Fixiphar (ID);",
"     </li>",
"     <li>",
"      Fixx (IN);",
"     </li>",
"     <li>",
"      Ixime (MY);",
"     </li>",
"     <li>",
"      Lanfix (ID);",
"     </li>",
"     <li>",
"      Longacef (VE);",
"     </li>",
"     <li>",
"      Maxicef (PE);",
"     </li>",
"     <li>",
"      Maxpro (ID);",
"     </li>",
"     <li>",
"      Minixime (MY);",
"     </li>",
"     <li>",
"      Necopen (ES);",
"     </li>",
"     <li>",
"      Neocef (PT);",
"     </li>",
"     <li>",
"      Novacef (AR);",
"     </li>",
"     <li>",
"      Oralcef (UY);",
"     </li>",
"     <li>",
"      Oroken (FR);",
"     </li>",
"     <li>",
"      Pancef (BG);",
"     </li>",
"     <li>",
"      Refixime (PH);",
"     </li>",
"     <li>",
"      Septipan (PH);",
"     </li>",
"     <li>",
"      Simfix (ID);",
"     </li>",
"     <li>",
"      Sixime (TH);",
"     </li>",
"     <li>",
"      Sofix (ID);",
"     </li>",
"     <li>",
"      Spaxim (ID);",
"     </li>",
"     <li>",
"      Starcef (ID);",
"     </li>",
"     <li>",
"      Supracef (FI);",
"     </li>",
"     <li>",
"      Supran (IL);",
"     </li>",
"     <li>",
"      Suprax (CZ, DE, GB, HU, IE, IT, NZ, RU, TR);",
"     </li>",
"     <li>",
"      Surixime (PH);",
"     </li>",
"     <li>",
"      Taxocef-O (PH);",
"     </li>",
"     <li>",
"      Tergecef (PH);",
"     </li>",
"     <li>",
"      Tocef (ID);",
"     </li>",
"     <li>",
"      Tricef (CN, PT, SE);",
"     </li>",
"     <li>",
"      Ultraxime (PH);",
"     </li>",
"     <li>",
"      Urticef (ID);",
"     </li>",
"     <li>",
"      Yafix (ID);",
"     </li>",
"     <li>",
"      Zefral (PH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F147368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs); which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F147387\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: 40% to 50%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Widely throughout the body and reaches therapeutic concentration in most tissues and body fluids, including synovial, pericardial, pleural, peritoneal; bile, sputum, and urine; bone, myocardium, gallbladder, and skin and soft tissue",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 65%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Normal renal function: 3-4 hours; Renal failure: Up to 11.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 2-6 hours; delayed with food",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (50% of absorbed dose as active drug); feces (10%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;1998 Guidelines for the Treatment of Sexually Transmitted Diseases. Centers for Disease Control and Prevention,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 1998, 47(RR-1):1-111.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ashkenazi S, Amir J, Waisman Y, et al, &ldquo;A Randomized, Double-Blind Study Comparing Cefixime and Trimethoprim-Sulfamethoxazole in the Treatment of Childhood Shigellosis,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1993, 123(5):817-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/8229498/pubmed\" id=\"8229498\" target=\"_blank\">",
"        8229498",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bradley JS, Byington CL, Shah SS, et al.  &ldquo;The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America&rdquo;,",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2011, 53(7):e25-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/21880587/pubmed\" id=\"21880587\" target=\"_blank\">",
"        21880587",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Sexually Transmitted Diseases Treatment Guidelines, 2010,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2010, 59(RR-12):1-110.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/21160459/pubmed\" id=\"21160459\" target=\"_blank\">",
"        21160459",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010:  Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections&rdquo;,",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2012, 61(31):590-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/22874837/pubmed\" id=\"22874837\" target=\"_blank\">",
"        22874837",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chow AW, Benninger MS, Brook I, et al, &ldquo;IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012, 54(8):e72-112.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/22438350/pubmed\" id=\"22438350\" target=\"_blank\">",
"        22438350",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Donowitz GR and Mandell GL, &ldquo;Beta-Lactam Antibiotics,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1988, 318(7):419-26 and 318(8):490-500.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/3277054/pubmed\" id=\"3277054\" target=\"_blank\">",
"        3277054",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Faulkner RD, Bohaycheck W, Lanc RA, et al, &ldquo;Pharmacokinetic of Cefixime in Young and Elderly,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 1988, 21(6):787-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/3410802/pubmed\" id=\"3410802\" target=\"_blank\">",
"        3410802",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Johnson CE, Carlin SA, Super DM, et al, &ldquo;Cefixime Compared With Amoxicillin for Treatment of Acute Otitis Media,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1991, 119(1):117-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/1906097/pubmed\" id=\"1906097\" target=\"_blank\">",
"        1906097",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levine WC, Berg AO, Johnson RE, et al, &ldquo;Development of Sexually Transmitted Diseases Treatment Guidelines, 1993. New Methods, Recommendations, and Research Priorities,&rdquo; STD Treatment Guidelines Project Team and Consultants,",
"      <i>",
"       Sex Transm Dis",
"      </i>",
"      , 1994, 21(2 Suppl):96-101.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Markham A and Brogden RN, &ldquo;Cefixime. A Review of Its Therapeutic Efficacy in Lower Respiratory Tract Infections,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1995, 49(6):1007-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/7641600/pubmed\" id=\"7641600\" target=\"_blank\">",
"        7641600",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Marshall WF and Blair JE, &ldquo;The Cephalosporins,&rdquo;",
"      <i>",
"       Mayo Clin Proc",
"      </i>",
"      , 1999, 74(2):187-95.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/10069359/pubmed\" id=\"10069359\" target=\"_blank\">",
"        10069359",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Public Health Agency of Canada, &ldquo;Canadian Guidelines on Sexually Transmitted Infections.\" Available at file://www.phac-aspc.gc.ca/std-mts/sti-its/alert/2011/alert-gono-eng.php. Accessed January 4, 2012.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schatz BS, Karavokiros KT, Taeubel MA, et al, &ldquo;Comparison of Cefprozil, Cefpodoxime Proxetil, Loracarbef, Cefixime, and Ceftibuten,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1996, 30(3):258-68.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/8833562/pubmed\" id=\"8833562\" target=\"_blank\">",
"        8833562",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smith GH, &ldquo;Oral Cephalosporins in Perspective,&rdquo;",
"      <i>",
"       DICP",
"      </i>",
"      , 1990, 24(1):45-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/44/16070/abstract-text/2405586/pubmed\" id=\"2405586\" target=\"_blank\">",
"        2405586",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9216 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-190.102.30.19-D906BBADCB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16070=[""].join("\n");
var outline_f15_44_16070=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147405\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147406\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147443\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147409\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147427\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147410\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147411\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147381\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147365\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147385\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147384\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14470550\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147450\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147441\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147388\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147369\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298989\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147374\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147401\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147377\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5951284\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147415\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147391\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147392\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6133204\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147379\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147393\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147368\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147387\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9216\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9216|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?9/38/9828?source=related_link\">",
"      Cefixime: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/32/38404?source=related_link\">",
"      Cefixime: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_44_16071="Plaque psoriasis 2";
var content_f15_44_16071=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87441&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Plaque psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 433px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A large, infiltrated,&nbsp;erythemathous plaque with well demarcated margins in a patient with plaque psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16071=[""].join("\n");
var outline_f15_44_16071=null;
var title_f15_44_16072="Etiologies of nasal symptoms: An overview";
var content_f15_44_16072=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiologies of nasal symptoms: An overview",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/44/16072/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16072/contributors\">",
"     Marilene B Wang, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/44/16072/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16072/contributors\">",
"     Jonathan Corren, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/44/16072/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16072/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/44/16072/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal obstruction, congestion, and other nasal symptoms are common complaints. There are numerous causes for nasal obstruction because of the complex anatomy of the nose and paranasal sinuses and the physiology of normal airflow through the nose.",
"   </p>",
"   <p>",
"    This topic provides an overview of the basic anatomy of the nose and paranasal sinuses and reviews structural problems that result in nasal symptoms. Inflammatory conditions causing nasal symptoms and medications and systemic medical problems that cause rhinitis are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/17/30999?source=see_link\">",
"     \"An overview of rhinitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=see_link\">",
"     \"Chronic nonallergic rhinitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NASAL ANATOMY AND FUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A basic understanding of the anatomy of the nose and paranasal sinuses is essential for the clinician evaluating nasal symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Nose",
"    </span>",
"    &nbsp;&mdash;&nbsp;The external nose is a pyramidal structure composed of skin, dorsal nasal bones, and upper and lower lateral cartilages (",
"    <a class=\"graphic graphic_figure graphicRef56105 \" href=\"UTD.htm?21/25/21905\">",
"     figure 1",
"    </a>",
"    ). In addition, the medial and lateral crura and columella contribute to the tip structure.",
"   </p>",
"   <p>",
"    The internal anatomy of the nose includes the following important structures:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The nasal septum is the midline structure dividing the nose into two nostrils and is composed of membranous, cartilaginous, and bony components (",
"      <a class=\"graphic graphic_figure graphicRef56105 \" href=\"UTD.htm?21/25/21905\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The lateral nasal wall consists of the superior, middle, and inferior turbinates, which are erectile structures composed of mucosa and spongy bone, covered with mucous membrane (",
"      <a class=\"graphic graphic_figure graphicRef67813 \" href=\"UTD.htm?33/24/34180\">",
"       figure 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef52743 \" href=\"UTD.htm?11/43/11967\">",
"       figure 3",
"      </a>",
"      ). The turbinates warm, humidify, and filter inspired air before its passage to the lungs. These structures swell or contract with changes in temperature, humidity, allergen exposure, and emotional perturbations. There is also a regular, cyclical pattern of turbinate swelling, which alternates between sides at intervals of two to five hours [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/1\">",
"       1",
"      </a>",
"      ]. This is sometimes referred to as the nasal cycle.",
"     </li>",
"     <li>",
"      The internal nasal valve consists of the junction between the upper lateral cartilage and septum, while the external nasal valve includes the lower lateral cartilages (alar cartilages), columella, and nasal vestibule (",
"      <a class=\"graphic graphic_figure graphicRef52471 \" href=\"UTD.htm?11/59/12208\">",
"       figure 4",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Paranasal sinuses",
"    </span>",
"    &nbsp;&mdash;&nbsp;The paranasal sinuses are paired, air-filled cavities located in the anterior mid-face (",
"    <a class=\"graphic graphic_figure graphicRef75249 \" href=\"UTD.htm?23/36/24143\">",
"     figure 5",
"    </a>",
"    ). Each of the sinuses has an ostium, a distinct bony opening, through which it drains. Although these structures are not part of the nasal airway, they play an important role in nasal symptoms, as disease processes involving the paranasal sinuses may lead to obstruction of sinus ostia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nasal cavity, with subsequent nasal congestion and obstructive symptoms.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The maxillary sinuses are the largest sinuses and are located behind the cheeks (",
"      <a class=\"graphic graphic_figure graphicRef75249 \" href=\"UTD.htm?23/36/24143\">",
"       figure 5",
"      </a>",
"      ). They are roughly triangular in shape. The natural ostium is elliptical in shape and located along the superior medial wall of the sinus, within the ostio-meatal complex. Acute inflammation in the maxillary sinuses may cause the cheeks to become tender to touch, or the upper jaw and upper teeth to ache.",
"     </li>",
"     <li>",
"      The ethmoid sinuses are located between the eyes, behind the bridge of the nose, and are composed of numerous small air cells that are filled with fluid at birth (",
"      <a class=\"graphic graphic_figure graphicRef75249 \" href=\"UTD.htm?23/36/24143\">",
"       figure 5",
"      </a>",
"      ). Pneumatization of the ethmoids begins at approximately one year of age. Inflammation of the ethmoid sinuses can cause pain between the eyes, tenderness along the sides of the nose, loss of smell, nasal congestion, and swelling of the peri-ocular tissues.",
"     </li>",
"     <li>",
"      The frontal sinuses are positioned in the midface, over the eyes, and drain through the frontal recess into the hiatus semilunaris in the ostio-meatal complex (",
"      <a class=\"graphic graphic_figure graphicRef75249 \" href=\"UTD.htm?23/36/24143\">",
"       figure 5",
"      </a>",
"      ). Acute inflammation of the frontal sinuses can cause the forehead to be painful to touch. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Ostio-meatal complex'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      The sphenoid sinuses are located behind the eyes and nasal structures (",
"      <a class=\"graphic graphic_figure graphicRef67813 \" href=\"UTD.htm?33/24/34180\">",
"       figure 2",
"      </a>",
"      ). These structures are present at birth, although pneumatization begins around age three and continues to develop through adulthood. Problems in the sphenoid sinuses may present with earache, deep aching at the top of the head, and neck pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Ostio-meatal complex",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ostio-meatal complex is a series of narrow bony openings and clefts along the lateral wall of the nose and includes the middle turbinates, uncinate process, hiatus semilunaris, ethmoid bulla, and natural ostium of the maxillary sinus (",
"    <a class=\"graphic graphic_figure graphicRef50120 \" href=\"UTD.htm?10/21/10579\">",
"     figure 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The ostio-meatal complex serves as a common drainage pathway for the frontal, maxillary, and ethmoid sinuses, and is critical for normal sinus drainage and ventilation. This important area frequently acts as a \"bottleneck\" when inflammation or other structural changes reduce its patency at various points (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77069 \" href=\"UTD.htm?34/31/35313\">",
"     image 1",
"    </a>",
"    ). When there is obstruction of the complex from polyps, thickened mucosa, or mucous, the alteration in airflow and sinus ventilation results in the sensation of nasal stuffiness or fullness and facial pain, even though the nasal passage itself may be relatively patent. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Normal airflow'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Nasopharynx",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nasopharynx is located posterior to the nasal cavity, superior to the soft palate and oropharynx. The anterior border of the nasopharynx consists of the paired choanae, separated by the septum, which form the posterior border of the nasal cavity. The roof of the nasopharynx is the inferior wall of the sphenoid sinus (",
"    <a class=\"graphic graphic_figure graphicRef67813 \" href=\"UTD.htm?33/24/34180\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Important structures within the nasopharynx include the adenoid pad, Eustachian tube orifices, and the fossa of Rosenmuller, a slit-like depression medial to the Eustachian tube orifice (",
"    <a class=\"graphic graphic_figure graphicRef67813 \" href=\"UTD.htm?33/24/34180\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     NORMAL AIRFLOW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airflow through the nose begins at the entrance to the nostrils, a circular area defined by the nasal alae and columella. The negative pressure of inspiration draws air back through the nasal passage, to the choanae, and then into the larynx, trachea, and bronchi (",
"    <a class=\"graphic graphic_figure graphicRef67813 \" href=\"UTD.htm?33/24/34180\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    During airflow through the nose, the turbinates, septum, and ostio-meatal complex contribute to natural turbulence of the air column. This turbulence is physiologically important, because alteration of any of these internal structures can affect the perception of airflow. As an example, a person with a large septal perforation will have a constant sensation of nasal obstruction due to disruption of the normal turbulence patterns, even though the nasal passage itself is widely patent.",
"   </p>",
"   <p>",
"    There is also airflow around the turbinates and into the natural ostia of the sinuses during normal respiration. Therefore, particles or allergens in the air can potentially affect both the nasal and sinus mucosa, resulting in inflammation throughout the upper airway.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CONGENITAL ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital abnormalities that cause nasal obstruction, such as congenital pyriform aperture stenosis, choanal atresia, and deviation of the septum, may present emergently after birth, as neonates are obligate nasal breathers (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73593 \" href=\"UTD.htm?5/60/6081\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Less severely affected patients may present later in life with unilateral nasal discharge",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    obstruction. These disorders are reviewed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35575?source=see_link\">",
"     \"Congenital anomalies of the nose\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ACQUIRED ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acquired abnormalities include enlarged adenoids, foreign bodies, disorders of the nasal septum, abnormalities of the nasal valve, and nasal polyps. Neoplastic disorders are reviewed below. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Tumors'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Enlarged adenoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large adenoid pad is the most common cause of nasal obstruction in a child. Additional symptoms of adenoid hypertrophy include mouth breathing, mucopurulent nasal discharge, snoring, and potentially sleep disordered breathing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11194?source=see_link&amp;anchor=H35#H35\">",
"     \"The pediatric physical examination: HEENT\", section on 'Adenoidal hypertrophy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/36/9801?source=see_link\">",
"     \"Mechanisms and predisposing factors for sleep related breathing disorders in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prolonged mouth breathing due to adenoid hypertrophy may affect facial and dental growth and development, resulting in the characteristic \"adenoid facies\" (ie, open mouth, flattening and elongation of the midface, retraction of the upper lip, and narrowing of the hard palate resulting in crowding of the maxillary teeth). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/55/19320?source=see_link\">",
"     \"Oral habits and orofacial development in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Foreign bodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Foreign bodies inserted into the nose may become lodged high in the nasal cavities or the paranasal sinuses. This is a common cause of both acute and chronic unexplained nasal symptoms in young children [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/4\">",
"     4",
"    </a>",
"    ]. In acute cases, the child's parent may be able to dislodge the object by mouth-to-mouth blowing, although items that have been in place for significant periods of time require surgical removal [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/21/17752?source=see_link\">",
"     \"Diagnosis and management of intranasal foreign bodies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28504?source=see_link\">",
"     \"Diagnosis and management of foreign bodies of the outer ear\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Disorders affecting the septum",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the most common causes of nasal obstruction is an acquired deviation of the septum. The septum is easily injured, and even minor blunt trauma may cause alteration in the cartilage",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bone of the septum. Traumatic or forceps delivery may result in damage to the septal cartilage at birth. Sports, motor vehicle accidents, and other traumatic events during a person's lifetime are common causes in older individuals. In addition, the normal aging process of cartilage will result in worsening of the deviation with time. Concomitant disease, such as allergic or vasomotor rhinitis or chronic rhinosinusitis, may potentiate the obstruction caused by a deviated septum.",
"   </p>",
"   <p>",
"    Septal perforation is a condition often seen in those who use intranasal cocaine. It may also result from septal surgery, atrophic rhinitis, granulomatosis with polyangiitis (Wegener's), and several other disorders (",
"    <a class=\"graphic graphic_table graphicRef64345 \" href=\"UTD.htm?33/9/33947\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/6-12\">",
"     6-12",
"    </a>",
"    ]. It is difficult to know how commonly the various disorders cause septal perforation, as the literature largely consists of case reports and small series. Despite the apparent increase in airflow through a perforated septum, the patient actually experiences the sensation of nasal congestion. This is due to the alteration in the normal airflow through the perforated septum. Excess crusting and bleeding are also common in patients with septal perforation, further contributing to a sense of congestion and discomfort. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/14/21738?source=see_link\">",
"     \"Respiratory tract involvement in granulomatosis with polyangiitis (Wegener's)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32970?source=see_link\">",
"     \"Cocaine abuse and dependence in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Nasal vestibulitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal vestibulitis, or nasal folliculitis, is an uncommon acute infection of the nasal vestibule, the area just inside the nostrils, usually with Staphylococcus. Precipitating factors include nose-picking or excessive nose blowing, which can result in crusting and bleeding around the nasal hair follicles. Nasal vestibulitis has not been associated with nasal steroid use.",
"   </p>",
"   <p>",
"    Prominent symptoms include pain and swelling, and the sudden onset of unusual tenderness upon touching or moving the nose generally prompts the patient to seek medical attention. Nasal obstruction is not usually reported. On examination, an area of swollen mucosa, crusting, or sometimes a pimple-like lesion on the nasal mucosa may be visible. The nose may appear swollen, erythematous and warm externally in some cases, although fever is not usually present. The septum is not usually affected because most of the hair follicles are located in the vestibular skin and mucosa.",
"   </p>",
"   <p>",
"    Treatment consists of the application of warm compresses and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33252?source=see_link\">",
"     mupirocin",
"    </a>",
"    nasal ointment twice daily for five days, or oral antibiotics if the infection appears to be widespread.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H217237\">",
"    <span class=\"h2\">",
"     Chronic nasal sores",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic nasal sores can be caused by a variety of inflammatory and infectious etiologies. Frequent nose picking or rubbing may lead to chronic infection of the nasal mucosa with Staphylococcus aureus, with development of ulceration, bleeding, and pain. Immunosuppressed individuals may develop infections from other bacteria, including Pseudomonas aeruginosa, and opportunistic microbes and viruses. Herpes simplex virus 1 may affect any mucous membrane, including oral cavity, lips, and nasal mucosa. Mycobacteria (tuberculosis, leprosy), syphilis, rhinoscleroma [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/13\">",
"     13",
"    </a>",
"    ], and fungal infections may rarely affect the nose, with resulting chronic nasal sores. Intranasal drug use such as cocaine can lead to chronic nasal sores, ulceration, and eventual septal perforation.",
"   </p>",
"   <p>",
"    Treatment of nasal sores includes topical antibiotic ointments such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33252?source=see_link\">",
"     mupirocin",
"    </a>",
"    and appropriate oral antibiotics for severe infections. A culture of the lesion may be helpful in directing antibiotic therapy. Helpful adjunctive therapies include saline irrigations, local nasal care with warm compresses, and avoidance of digital manipulation.",
"   </p>",
"   <p>",
"    A nasal sore which does not heal after such measures may require biopsy to establish a diagnosis of a more unusual systemic disease. Less common etiologies for nasal sores include granulomatous diseases such as granulomatosis with polyangiitis (Wegener's) and sarcoid. Rare diseases include lethal midline granuloma or sinonasal lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=see_link&amp;anchor=H11698545#H11698545\">",
"     \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\", section on 'Ear, nose, and throat'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link\">",
"     \"Clinical manifestations and diagnosis of sarcoidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4249?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of extranodal NK/T cell lymphoma, nasal type\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Abnormalities of the nasal valve",
"    </span>",
"    &nbsp;&mdash;&nbsp;The internal nasal valve is formed by the junction of the upper lateral cartilage with the septum, as discussed previously (",
"    <a class=\"graphic graphic_figure graphicRef52471 \" href=\"UTD.htm?11/59/12208\">",
"     figure 4",
"    </a>",
"    ). The external nasal valve is formed by the nasal alae and lateral crura.",
"   </p>",
"   <p>",
"    The most common symptom of nasal valve weakness is nasal congestion, particularly with deep inspiration, because the negative pressure causes collapse of the nasal valve.",
"   </p>",
"   <p>",
"    The most common cause of internal nasal valve weakness is iatrogenic, resulting from overzealous cartilage resection during rhinoplasty. The internal nasal valve may also be weakened by nasal trauma. External nasal valve weakness may be congenital or a result of traumatic injury. Correction of nasal valve weakness requires surgery using cartilage grafts to buttress and support the existing cartilage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Nasal polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal polyps are abnormal grey, glistening masses filled with inflammatory material, which may form in the nasal cavity or paranasal sinuses (",
"    <a class=\"graphic graphic_figure graphicRef50105 \" href=\"UTD.htm?26/4/26688\">",
"     figure 7",
"    </a>",
"    ). Polyps may be diagnosed clinically by their characteristic appearance on exam with a nasal speculum or rhinoscope. Polyps are also identifiable on computed tomography (CT) examination. In adults, nasal polyps are frequently associated with chronic sinusitis, asthma, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    sensitivity, in the syndrome of \"aspirin-exacerbated respiratory disease\" (AERD). Some patients have concomitant allergic rhinitis or allergic fungal sinusitis. In children, nasal polyps are most commonly associated with cystic fibrosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/0/39944?source=see_link\">",
"     \"Aspirin exacerbated respiratory disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/49/28442?source=see_link\">",
"     \"Cystic fibrosis: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Large or extensive polyps cause symptoms of nasal airway congestion or blockage, thick discharge, and anosmia. Surgery can offer temporary relief, although polyps tend to recur within a few months to years following this intervention alone. Continued medical management of the underlying etiology is therefore mandatory after surgery, including intranasal glucocorticoids, allergen immunotherapy (if applicable), antileukotriene therapy, and daily lavage of the sinuses. In patients with AERD,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    desensitization followed by long-term daily therapy may be an additional therapeutic option. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/59/31672?source=see_link\">",
"     \"NSAIDs (including aspirin): Allergic and pseudoallergic reactions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/54/18281?source=see_link\">",
"     \"Aspirin exacerbated respiratory disease: NSAID challenge and desensitization\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/4/30794?source=see_link&amp;anchor=H21#H21\">",
"     \"Management of chronic rhinosinusitis\", section on 'CRS with nasal polyposis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Mucoceles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mucoceles are benign, epithelium-lined cysts filled with mucus, which can form in the paranasal sinuses. These structures may cause symptoms if sufficiently large or if exerting pressure on surrounding anatomic structures. Symptomatic mucoceles typically require surgical intervention.",
"   </p>",
"   <p>",
"    The ethmoid and frontal sinuses are most commonly affected. Mucoceles in these areas may cause sinus obstruction, remodeling of the sinus bone, or deformation of the orbit or forehead (if very large). Similarly, sphenoid mucoceles may cause symptoms of headache, eye pressure, and retro-orbital pain.",
"   </p>",
"   <p>",
"    In contrast, mucoceles in the maxillary sinus are less common and generally do not cause symptoms unless they are very large and obstruct the ostio-meatal complex, resulting in post-obstructive sinusitis.",
"   </p>",
"   <p>",
"    Mucoceles should be differentiated from sinus retention cysts. Unlike mucoceles, sinus retention cysts do not result in expansion and thinning of the bony sinus walls. Sinus retention cysts are present in 8 to 30 percent of patients undergoing sinus imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/16-18\">",
"     16-18",
"    </a>",
"    ], and usually do not cause symptoms or compress surrounding structures unless very large and causing mechanical obstruction of a sinus. One study found that cysts &gt;20 mm and bilateral cysts were more likely to progress over time and cause symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/19\">",
"     19",
"    </a>",
"    ]. However, most cysts do not change significantly over time, do not require serial imaging, and do not necessitate surgical removal [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/20-22\">",
"     20-22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign and malignant tumors in the nasal cavity and sinuses may cause nasal obstruction and discharge. Early symptoms may be vague, and include nasal congestion or obstruction, mucoid drainage due to obstruction, retained secretions in the sinuses, and rarely bleeding.",
"   </p>",
"   <p>",
"    Diagnosis is usually made by nasal endoscopy and biopsy. Referral to an otolaryngology specialist is indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Benign",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign tumors include inverted papilloma, which usually occurs on the lateral wall of the nose, other squamous papillomas, and rarely hemangiomas and hemangiopericytomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/4/12362?source=see_link\">",
"     \"Pathology of head and neck neoplasms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Benign tumors of the nasopharynx can also cause symptoms of nasal obstruction. Juvenile nasal angiofibroma is a rare benign tumor, accounting for 0.05 percent of head and neck tumors, that occurs almost exclusively in teenage males [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/23\">",
"     23",
"    </a>",
"    ]. These tumors experience rapid growth during puberty. The triad of nasal obstruction, epistaxis, and nasal drainage is a common combination of signs and symptoms; serous otitis media and diminished hearing also may be present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=see_link\">",
"     \"Epidemiology and etiology of epistaxis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Malignant",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant tumors in the sinonasal region are rare, accounting for less than 1 percent of all malignant tumors and 3 percent of malignant tumors of the upper aerodigestive tract [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nasal congestion, and discharge are common symptoms that may be caused by an array of benign disorders. Consideration of a malignancy of the nasal or sinus cavities, however, should occur when these symptoms present in association with one or more of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Swelling or deformity of the nose or face",
"     </li>",
"     <li>",
"      Persistent facial, dental, ear, or neck pain",
"     </li>",
"     <li>",
"      Recurrent epistaxis or bloody nasal discharge in the absence of an obvious cause",
"     </li>",
"     <li>",
"      Visual changes, especially diplopia",
"     </li>",
"     <li>",
"      Neurologic changes, such as facial numbness or cranial nerve dysfunction",
"     </li>",
"     <li>",
"      Proptosis",
"     </li>",
"     <li>",
"      Neck mass or asymmetry of the face",
"     </li>",
"     <li>",
"      Trismus (ie, restricted ability to open the jaw)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Nasal cavity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignancies of the nasal cavity typically present with nasal obstruction, congestion, proptosis, visual changes, diplopia, facial pain or numbness, and bleeding. In late stages, cranial nerve palsies may develop due to involvement and invasion of the skull base.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Paranasal sinuses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignancies of the paranasal sinuses most commonly cause facial or dental pain, nasal obstruction, and epistaxis. Physical and radiographic investigation is indicated when these symptoms occur, in the absence of a clear cause, in a patient over 40. The combination of pain with unilateral nasal obstruction should also prompt evaluation for malignancies. Growths involving the maxillary sinuses may cause dentures to become ill-fitting. Ocular symptoms may occur with malignancies of the ethmoid sinus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/44/30407?source=see_link\">",
"     \"Overview of head and neck cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Specific malignancies",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common malignant tumor in the nasal cavity is squamous cell carcinoma. These patients usually present with nasal obstruction, sinusitis due to obstruction from the mass, and bleeding in early stages. Patients with late stage carcinoma may have facial pain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      numbness, visual changes, diplopia, proptosis, and bleeding. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/59/43959?source=see_link\">",
"       \"Overview of treatment for head and neck squamous cell cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Malignant tumors may also occur in the numerous mucous glands of the respiratory epithelium and include adenocarcinoma and adenoid cystic carcinoma. When these tumors involve the nasal cavity or maxillary sinus, they can produce nasal obstruction, congestion, vision changes, or trismus. Minor salivary gland tumors involving the nasopharynx usually present at an advanced stage, often with invasion of the skull base, intracranial extension, and involvement of cranial nerves. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=see_link\">",
"       \"Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Olfactory neuroblastoma is a malignant tumor that originates in the roof of the nose from the olfactory epithelium [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/26\">",
"       26",
"      </a>",
"      ]. The most common symptom is unilateral nasal congestion or obstruction. Other presenting symptoms include nasal congestion, anosmia, recurrent epistaxis, pain, frontal headache, and diplopia. Physical examination may reveal a red-brown, polypoid mass located high in the nasal cavity. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/46/12008?source=see_link\">",
"       \"Olfactory neuroblastoma (esthesioneuroblastoma)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Melanomas rarely occur in the nose and paranasal sinuses and usually originate in the mucosa. Melanomas in the nose and paranasal sinuses usually present as a pigmented lesion in the mucosa, although amelanotic melanomas do occur. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/44/23241?source=see_link\">",
"       \"Paranasal sinus cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nasopharyngeal carcinoma (NPC) presents with a mass in the neck in up to 90 percent of patients. Unilateral serous otitis media may occur due to eustachian tube obstruction. Headache and cranial nerve abnormalities may be present at diagnosis. NPC is endemic in southeast China, where it is associated with the Epstein- Barr virus, while the incidence is extremely low outside of these areas [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16072/abstract/27\">",
"       27",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/36/26184?source=see_link\">",
"       \"Epidemiology, etiology, and diagnosis of nasopharyngeal carcinoma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/12/11457?source=see_link\">",
"       \"Patient information: Deviated septum (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/18/29985?source=see_link\">",
"       \"Patient information: Nasal polyps (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Structural causes of nasal symptoms include swelling from inflammation, infection, or polyps, congenital or acquired anatomic abnormalities, and mass lesions. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The anatomy of the nose and paranasal sinuses is complex. Important structures include the internal and external nasal valves, the nasal septum, the turbinates (erectile structures along the lateral wall that swell and contract in response to numerous stimuli), and the ostio-meatal complex (an area in which multiple structures interface and where the frontal, ethmoid, and maxillary sinuses drain into the nose) (",
"      <a class=\"graphic graphic_figure graphicRef67813 \" href=\"UTD.htm?33/24/34180\">",
"       figure 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef52471 \" href=\"UTD.htm?11/59/12208\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef75249 \" href=\"UTD.htm?23/36/24143\">",
"       figure 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef50120 \" href=\"UTD.htm?10/21/10579\">",
"       figure 6",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Nasal anatomy and function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During airflow through the nose, the turbinates, septum, and ostio-meatal complex contribute to natural turbulence of the air column. Alteration of any of these internal structures can affect the normal patterns of turbulence and result in the subjective sensation of congestion. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Normal airflow'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Congenital abnormalities that cause nasal obstruction, such as congenital pyriform aperture stenosis, choanal atresia, and congenital deviation of the septum, may present emergently after birth, as neonates are obligate nasal breathers. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Congenital abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acquired structural causes of nasal symptoms include enlarged adenoids, foreign bodies, disorders of the nasal septum, abnormalities of the nasal valve, inflammatory conditions, nasal polyps, and neoplastic disorders. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Acquired abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In infants and small children, nasal trauma during delivery, adenoidal hypertrophy, and foreign bodies inserted into the nose are common causes of nasal symptoms. In older children and adults, generalized swelling due to rhinitis, obstruction from septal disorders, nasal polyps, or overly aggressive sinus surgery are other structural causes of nasal symptoms. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Acquired abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Benign and malignant tumors can also cause nasal symptoms, although these conditions are uncommon. Malignancies should be considered in patients who present with nasal symptoms accompanied by localized pain in the head or neck, numbness, bleeding, proptosis, diplopia, or cranial nerve abnormalities. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Tumors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/1\">",
"      Baraniuk JN, Kim D. Nasonasal reflexes, the nasal cycle, and sneeze. Curr Allergy Asthma Rep 2007; 7:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/2\">",
"      Vercruysse JP, Wojciechowski M, Koninckx M, et al. Congenital nasal pyriform aperture stenosis: a rare cause of neonatal nasal obstruction. J Pediatr Surg 2006; 41:e5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/3\">",
"      Samadi DS, Shah UK, Handler SD. Choanal atresia: a twenty-year review of medical comorbidities and surgical outcomes. Laryngoscope 2003; 113:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/4\">",
"      Higo R, Matsumoto Y, Ichimura K, Kaga K. Foreign bodies in the aerodigestive tract in pediatric patients. Auris Nasus Larynx 2003; 30:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/5\">",
"      Botma M, Bader R, Kubba H. 'A parent's kiss': evaluating an unusual method for removing nasal foreign bodies in children. J Laryngol Otol 2000; 114:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/6\">",
"      Trimarchi M, Nicolai P, Lombardi D, et al. Sinonasal osteocartilaginous necrosis in cocaine abusers: experience in 25 patients. Am J Rhinol 2003; 17:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/7\">",
"      Willkens RF, Roth GJ, Novak A, Walike JW. Perforation of nasal septum in rheumatic diseases. Arthritis Rheum 1976; 19:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/8\">",
"      Cannady SB, Batra PS, Koening C, et al. Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases. Laryngoscope 2009; 119:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/9\">",
"      Mailliez A, Baldini C, Van JT, et al. Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients. Br J Cancer 2010; 103:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/10\">",
"      Brahn E, Pegues DA, Yao Q, Craft N. Mucocutaneous leishmaniasis masquerading as Wegener granulomatosis. J Clin Rheumatol 2010; 16:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/11\">",
"      Kameswaran M. Fibre-optic endoscopy in atrophic rhinitis. J Laryngol Otol 1991; 105:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/12\">",
"      Lanier B, Kai G, Marple B, Wall GM. Pathophysiology and progression of nasal septal perforation. Ann Allergy Asthma Immunol 2007; 99:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/13\">",
"      Gaafar HA, Gaafar AH, Nour YA. Rhinoscleroma: an updated experience through the last 10 years. Acta Otolaryngol 2011; 131:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/14\">",
"      Aozasa K, Zaki MA. Epidemiology and pathogenesis of nasal NK/T-cell lymphoma: a mini-review. ScientificWorldJournal 2011; 11:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/15\">",
"      Parker NP, Pearlman AN, Conley DB, et al. The dilemma of midline destructive lesions: a case series and diagnostic review. Am J Otolaryngol 2010; 31:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/16\">",
"      Rodrigues CD, Freire GF, Silva LB, et al. Prevalence and risk factors of mucous retention cysts in a Brazilian population. Dentomaxillofac Radiol 2009; 38:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/17\">",
"      B&oacute;sio JA, Tanaka O, Rovigatti E, de Gruner SK. The incidence of maxillary sinus retention cysts in orthodontic patients. World J Orthod 2009; 10:e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/18\">",
"      Moon IJ, Lee JE, Kim ST, et al. Characteristics and risk factors of mucosal cysts in the paranasal sinuses. Rhinology 2011; 49:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/19\">",
"      Moon IJ, Kim SW, Han DH, et al. Mucosal cysts in the paranasal sinuses: long-term follow-up and clinical implications. Am J Rhinol Allergy 2011; 25:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/20\">",
"      Casamassimo PS, Lilly GE. Mucosal cysts of the maxillary sinus: a clinical and radiographic study. Oral Surg Oral Med Oral Pathol 1980; 50:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/21\">",
"      Wang JH, Jang YJ, Lee BJ. Natural course of retention cysts of the maxillary sinus: long-term follow-up results. Laryngoscope 2007; 117:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/22\">",
"      Albu S. Symptomatic maxillary sinus retention cysts: should they be removed? Laryngoscope 2010; 120:1904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/23\">",
"      Gullane PJ, Davidson J, O'Dwyer T, Forte V. Juvenile angiofibroma: a review of the literature and a case series report. Laryngoscope 1992; 102:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/24\">",
"      Cancer incidence in five continents. Volume VIII. IARC Sci Publ 2002; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/25\">",
"      Osguthorpe JD. Sinus neoplasia. Arch Otolaryngol Head Neck Surg 1994; 120:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/26\">",
"      Cunningham MJ, Lin DT, Curry WT Jr, et al. Case records of the Massachusetts General Hospital. Case 20-2007. An 11-year-old boy with a calcified mass in the nose. N Engl J Med 2007; 356:2721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16072/abstract/27\">",
"      Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet 2005; 365:2041.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7535 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-07C7D38949-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16072=[""].join("\n");
var outline_f15_44_16072=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NASAL ANATOMY AND FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Nose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Paranasal sinuses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Ostio-meatal complex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Nasopharynx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      NORMAL AIRFLOW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CONGENITAL ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ACQUIRED ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Enlarged adenoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Foreign bodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Disorders affecting the septum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Nasal vestibulitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H217237\">",
"      Chronic nasal sores",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Abnormalities of the nasal valve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Nasal polyps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Mucoceles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Benign",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Malignant",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Nasal cavity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Paranasal sinuses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Specific malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/7535\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/7535|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/31/35313\" title=\"diagnostic image 1\">",
"      Normal sinus CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/60/6081\" title=\"diagnostic image 2\">",
"      Choanal atresia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/7535|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/25/21905\" title=\"figure 1\">",
"      Nose external anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/24/34180\" title=\"figure 2\">",
"      Nose lat wall nasopharynx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/43/11967\" title=\"figure 3\">",
"      Internal nasal exam",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/59/12208\" title=\"figure 4\">",
"      Nasal valves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/36/24143\" title=\"figure 5\">",
"      Anatomic location of sinuses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/21/10579\" title=\"figure 6\">",
"      Ostio-meatal complex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/4/26688\" title=\"figure 7\">",
"      Nasal polyps in nostril",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/7535|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/9/33947\" title=\"table 1\">",
"      Etiologies of nasal septal perforation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/17/30999?source=related_link\">",
"      An overview of rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/0/39944?source=related_link\">",
"      Aspirin exacerbated respiratory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/54/18281?source=related_link\">",
"      Aspirin exacerbated respiratory disease: NSAID challenge and desensitization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=related_link\">",
"      Chronic nonallergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=related_link\">",
"      Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4249?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of extranodal NK/T cell lymphoma, nasal type",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=related_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32970?source=related_link\">",
"      Cocaine abuse and dependence in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/47/35575?source=related_link\">",
"      Congenital anomalies of the nose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/49/28442?source=related_link\">",
"      Cystic fibrosis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28504?source=related_link\">",
"      Diagnosis and management of foreign bodies of the outer ear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/21/17752?source=related_link\">",
"      Diagnosis and management of intranasal foreign bodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/16/27912?source=related_link\">",
"      Epidemiology and etiology of epistaxis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/36/26184?source=related_link\">",
"      Epidemiology, etiology, and diagnosis of nasopharyngeal carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/4/30794?source=related_link\">",
"      Management of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/36/9801?source=related_link\">",
"      Mechanisms and predisposing factors for sleep related breathing disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/59/31672?source=related_link\">",
"      NSAIDs (including aspirin): Allergic and pseudoallergic reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/46/12008?source=related_link\">",
"      Olfactory neuroblastoma (esthesioneuroblastoma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/55/19320?source=related_link\">",
"      Oral habits and orofacial development in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/44/30407?source=related_link\">",
"      Overview of head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/59/43959?source=related_link\">",
"      Overview of treatment for head and neck squamous cell cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/44/23241?source=related_link\">",
"      Paranasal sinus cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/4/12362?source=related_link\">",
"      Pathology of head and neck neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/12/11457?source=related_link\">",
"      Patient information: Deviated septum (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/18/29985?source=related_link\">",
"      Patient information: Nasal polyps (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/14/21738?source=related_link\">",
"      Respiratory tract involvement in granulomatosis with polyangiitis (Wegener's)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=related_link\">",
"      Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11194?source=related_link\">",
"      The pediatric physical examination: HEENT",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_44_16073="Pathogenesis of nonalcoholic fatty liver disease";
var content_f15_44_16073=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis of nonalcoholic fatty liver disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/44/16073/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16073/contributors\">",
"     David A Tendler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/44/16073/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16073/contributors\">",
"     Keith D Lindor, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/44/16073/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16073/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/44/16073/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonalcoholic fatty liver disease (NAFLD) is a clinico-histopathological entity with histological features that resemble alcohol-induced liver injury, but by definition, it occurs in patients with little or no history of alcohol consumption. It encompasses a histological spectrum that ranges from fat accumulation in hepatocytes without concomitant inflammation or fibrosis (simple hepatic steatosis) to hepatic steatosis with a necroinflammatory component (steatohepatitis) that may or may not have associated fibrosis. The latter condition, referred to as nonalcoholic steatohepatitis (NASH), may progress to cirrhosis in up to 20 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/1\">",
"     1",
"    </a>",
"    ]. NASH is now recognized to be a leading cause of cryptogenic cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis of nonalcoholic fatty liver disease has not been fully elucidated. The most widely supported theory implicates insulin resistance as the key mechanism leading to hepatic steatosis, and perhaps also to steatohepatitis. Others have proposed that a \"second hit\", or additional oxidative injury, is required to manifest the necroinflammatory component of steatohepatitis. Hepatic iron, leptin, anti-oxidant deficiencies, and intestinal bacteria have all been suggested as potential oxidative stressors.",
"   </p>",
"   <p>",
"    This topic review will focus on the pathogenesis of NAFLD. An approach to such patients is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38105?source=see_link\">",
"     \"Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23882?source=see_link\">",
"     \"Natural history and management of nonalcoholic fatty liver disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CAUSES OF TRIGLYCERIDE ACCUMULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatic steatosis is a manifestation of excessive triglyceride accumulation in the liver. This can occur from the excessive importation of free fatty acids (FFA) from adipose tissue, from diminished hepatic export of FFA (secondary to reduced synthesis or secretion of VLDL), or from impaired beta-oxidation of FFA. The major sources of triglycerides are from fatty acids stored in adipose tissue and fatty acids newly made within the liver through de novo lipogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Excessive importation of FFA can result from either increased delivery of triglycerides to the liver (as seen with obesity and rapid weight loss), or from excessive conversion of carbohydrates and proteins to triglycerides (eg, secondary to overfeeding or use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"       total parenteral nutrition",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Impaired VLDL synthesis and secretion can result from abetalipoproteinemia, protein malnutrition, or choline deficiency. Patients with NASH may have a defect in postprandial Apo B secretion, leading to triglyceride accumulation [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/4\">",
"       4",
"      </a>",
"      ]. In addition, a defect in the lipidation of Apo B, caused by an inhibition of microsomal triglyceride transfer protein (MTP), may be a key mechanism in drug-induced NAFLD, such as seen with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"       amiodarone",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"       tetracycline",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/5\">",
"       5",
"      </a>",
"      ]. Depletion of the orphan receptor small heterodimer partner (SHP) results in increased VLDL secretion, elevated MTP levels, and increased insulin sensitivity, whereas induction of SHP results in the rapid accumulation of hepatocyte lipids [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/6\">",
"       6",
"      </a>",
"      ]. Impaired VLDL synthesis and secretion were also more apparent in patients with NASH compared with patients with hepatic steatosis [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/7\">",
"       7",
"      </a>",
"      ]. This may have resulted in the induction of lipid oxidation and oxidative hepatocyte damage.",
"     </li>",
"     <li>",
"      Treatment of hypertriglyceridemia with eicosapentaenoic acid (EPA) reduces steatosis, oxidative stress, inflammation, and progression of fibrosis in a NASH animal model [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Impaired beta-oxidation of FFA to ATP may be seen with vitamin B5 (pantothenic acid) deficiency, excessive alcohol consumption, or coenzyme A deficiency (as can occur with valproic acid or chronic",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      use). Activation of peroxisome proliferator-activated receptor alpha appears to have a central role in stimulating beta-oxidation and disposing hepatic fatty acids in NASH [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/9\">",
"       9",
"      </a>",
"      ]. The ability to recover from hepatic ATP depletion is severely impaired in patients with obesity-related NASH [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/10\">",
"       10",
"      </a>",
"      ]. Compromised hepatic ATP homeostasis may predispose to injury from other insults. Adiponectin, a fat derived hormone, appears to have a pivotal role in improving fatty acid oxidation and decreasing fatty acid synthesis [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/11\">",
"       11",
"      </a>",
"      ]. Administration of adiponectin improved hepatomegaly, steatosis, and ALT levels in obese, leptin deficient mice. Also implicated in the steatosis pathway is the cannabinoid receptor type 1 (CB1). Administration of a CB1 receptor antagonist rapidly abolished hepatic steatosis, improved aminotransferase levels, reduced the levels of proinflammatory cytokines, and increased adiponectin levels in leptin-deficient mice [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Triglyceride synthesis and oxidation appear to be regulated, at least in part, by the enzyme acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1). DGAT1 deficient hepatocytes were protected from hepatic steatosis by reducing synthesis and increasing oxidation of fatty acids in an animal knockout model. DGAT1 activity was necessary for the manifestation of hepatic steatosis [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Micro RNA (MiRNA) also has a role in hepatocellular lipid metabolism and immunity. These are small non-coding RNAs that post-translationally modulate gene function and are involved in cellular processes, including cellular proliferation, inflammation, and apoptosis [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/14\">",
"       14",
"      </a>",
"      ]. Alterations in MiRNA activity result in hepatocellular injury, apoptosis, and portal fibrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/15\">",
"       15",
"      </a>",
"      ]. In NAFLD, specific MiRNA appear to regulate genes involved in fatty acid biosynthesis. Antagonism of specific MiRNA leads to decreased fatty acid synthesis and increased hepatic fatty acid oxidation [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INSULIN RESISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Insulin resistance has a key role in the development of hepatic steatosis and, potentially, steatohepatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/17-23\">",
"     17-23",
"    </a>",
"    ]. Obesity and type 2 diabetes, conditions associated with peripheral insulin resistance, are frequently observed in patients with NAFLD. Insulin resistance has also been observed in patients with NASH who are not obese and those who have normal glucose tolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/19,24-26\">",
"     19,24-26",
"    </a>",
"    ]. Despite the strong association, not all patients with NASH exhibit insulin resistance. This suggests that NASH may be a heterogeneous syndrome with more than one cause.",
"   </p>",
"   <p>",
"    The genetic basis for insulin resistance associated with NASH remains unclear. One report found an association with certain polymorphisms in the gene encoding for apoliprotein C3 [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/27\">",
"     27",
"    </a>",
"    ], while another study demonstrated that IL-6 polymorphisms are associated with NAFLD and markers of insulin resistance and inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/28\">",
"     28",
"    </a>",
"    ]. A third report found polymorphisms in a gene encoding for protein expressed in adipose tissue (adiponutrin) and involved in triglyceride metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/29\">",
"     29",
"    </a>",
"    ]. Certain variants of the gene were strongly associated with the histologic severity of NAFLD. In addition, alterations in the transcriptional activity of the peroxisome proliferator-activated receptor &gamma; coactivator 1&alpha; (PPARGC1A) promoter correlated with the insulin resistance phenotype and the presence of NAFLD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Increases in visceral adipose tissue and intrahepatic fat correlate with increased gluconeogenesis, increased free fatty acid levels, and insulin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/31\">",
"     31",
"    </a>",
"    ]. Visceral fat has also been associated with liver inflammation and fibrosis in patients with NASH independently of insulin resistance, an effect possibly mediated by interleukin-6 (a proinflammatory cytokine) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/32\">",
"     32",
"    </a>",
"    ]. Increased expression of hepatic interleukin-6 correlated with insulin resistance in another report [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/33\">",
"     33",
"    </a>",
"    ]. Several other cytokines and adipokines involved in insulin receptor signaling appear to be altered in omental adipose tissue of NASH patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/34\">",
"     34",
"    </a>",
"    ]. The activation of tumor necrosis factor alpha-converting enzyme (TACE) correlated with levels of insulin resistance, macrovesicular steatosis, and balloon degeneration in an animal model [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further supporting the role of insulin resistance are the observations from pilot studies, which have demonstrated beneficial effects of glucose-sensitizing medications in patients with NAFLD. Treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2472?source=see_link\">",
"     rosiglitazone",
"    </a>",
"    reduced the expression of hepatic acute phase reactants (C-reactive protein and serum amyloid A), suggesting that improvements in insulin sensitivity correspond with a reduction in inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/36\">",
"     36",
"    </a>",
"    ]. Similarly,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/28/43463?source=see_link\">",
"     pioglitazone",
"    </a>",
"    therapy led to significant improvements in steatosis and necroinflammation in patients with NASH and impaired glucose tolerance, correlating with decreases in adipose tissue insulin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/37\">",
"     37",
"    </a>",
"    ]. In other reports, patients with NAFLD and glucose intolerance were significantly more insulin resistant than glucose intolerant patients without fatty liver [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23882?source=see_link&amp;anchor=H254497165#H254497165\">",
"     \"Natural history and management of nonalcoholic fatty liver disease in adults\", section on 'Thiazolidinediones'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Resistance to the action of insulin results in important changes in lipid metabolism. These include enhanced peripheral lipolysis, increased triglyceride synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/40\">",
"     40",
"    </a>",
"    ], and increased hepatic uptake of fatty acids. Each of these may contribute to the accumulation of hepatocellular triglyceride [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/18\">",
"     18",
"    </a>",
"    ], which in turn results in a preferential shift from carbohydrate to FFA beta-oxidation, an occurrence that has been demonstrated in patients with insulin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/18,41\">",
"     18,41",
"    </a>",
"    ]. Significantly increased FFA levels have been observed in patients with NAFLD and type 2 diabetes mellitus, compared with type 2 diabetics without NAFLD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/31/36346?source=see_link&amp;anchor=H17#H17\">",
"     \"Pathogenesis of type 2 diabetes mellitus\", section on 'Role of diet, obesity, and inflammation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The molecular pathways leading to insulin resistance are complex and have not been completely elucidated. Several molecules appear to be involved in interfering with the actions of insulin on a cellular level.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H366045064\">",
"    <span class=\"h1\">",
"     HEPATOCELLULAR INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;FFAs are inducers of several cytochrome p-450 microsomal lipoxygenases, capable of producing hepatotoxic free oxygen radical species [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/42\">",
"     42",
"    </a>",
"    ]. Furthermore, the shift to FFA beta-oxidation in the setting of preexisting defects in mitochondrial oxidative phosphorylation may result in increased free radical formation, hepatocellular injury, and fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/18\">",
"     18",
"    </a>",
"    ]. Electron microscopy of hepatocytes from patients with NAFLD demonstrated that significant mitochondrial structural abnormalities were present in patients with NASH, but not those with simple hepatic steatosis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/18\">",
"     18",
"    </a>",
"    ]. These investigators hypothesized that, in the absence of these mitochondrial defects, peripheral insulin resistance will lead only to the development of simple fatty liver. Consistent with this theory is the observation that several genes important for mitochondrial function were significantly underexpressed in NASH patients, suggesting that there is a transcriptional or pretranscriptional basis for impaired mitochondrial function [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/43\">",
"     43",
"    </a>",
"    ]. On the other hand, it is possible that mitochondrial structural abnormalities may simply be a consequence of increased lipid peroxidation since lipid peroxidation products alter both mitochondrial DNA and mitochondrial respiration [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Others have suggested that the development of hepatocellular injury requires the presence of both insulin resistance and a second defect that results in the accumulation of damaging free oxygen radical species. Several potential oxidative stressors have been proposed to result in necroinflammation.",
"   </p>",
"   <p>",
"    The activation of nuclear factor-K&beta; and increased cytokine production appear to mediate the hepatocyte inflammatory process. Numerous proinflammatory cytokines and inflammatory mediators have been identified as having a role in hepatocyte inflammation and injury, including the activation of TNF-alpha, the complement system [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/46\">",
"     46",
"    </a>",
"    ], plasma myeloperoxidase (MPO) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/47\">",
"     47",
"    </a>",
"    ], and natural killer cells [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/48\">",
"     48",
"    </a>",
"    ], among others.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ANTIOXIDANTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipid peroxidation and free oxygen radical species can deplete antioxidant enzymes, such as glutathione, vitamin E,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    , and vitamin C, thus rendering the liver susceptible to oxidative injury [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Serum levels of xanthine oxidase, a generator of reactive oxygen species, are higher in patients with NASH compared with controls, whereas levels of multiple antioxidant enzymes are lower [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/51\">",
"     51",
"    </a>",
"    ]. In addition, the induction of heme oxygenase-1, an antioxidant defense enzyme, interrupted the progression of steatohepatitis by inducing an antioxidant pathway and suppressing proinflammatory cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/52\">",
"     52",
"    </a>",
"    ]. A correlation between disease severity and increased expression of oxidative scavenger receptors has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/53\">",
"     53",
"    </a>",
"    ]. Serotonin has been implicated as a source of reactive oxygen species in NASH. Increased catabolism of serotonin resulted in increased levels of reactive oxidative species and necroinflammation in an animal NASH model [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is indirect evidence supporting the role of antioxidants in preventing oxidative liver injury. Vitamin E therapy normalized serum aminotransferase elevations in children with fatty liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/55\">",
"     55",
"    </a>",
"    ]. In another report, a six-month course of combination therapy with vitamin E and vitamin C resulted in significant histological improvement, both with respect to inflammation and fibrosis scores [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/56\">",
"     56",
"    </a>",
"    ]. In a third report, dietary intake of antioxidant vitamins was significantly lower in NASH patients, compared with age and BMI matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The beneficial effect of antioxidant therapy may be mediated by regulatory T cells, which are depleted in steatotic mice [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/57\">",
"     57",
"    </a>",
"    ]. Antioxidant therapy resulted in reduced regulatory T cell apoptosis and decreased hepatic inflammation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     IRON",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased hepatic iron may also have a role in the development of NASH.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Insulin resistance is associated with increased hepatic iron levels [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/58\">",
"       58",
"      </a>",
"      ], and improved glycemic control is associated with improvements in serum ferritin and hepatic iron concentrations [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The prevalence of heterozygosity for the hemochromatosis gene mutation (HFE) may be increased in patients with NASH associated with increased hepatic iron concentrations and ALT levels [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/60\">",
"       60",
"      </a>",
"      ]. In one report, there was a significantly increased prevalence of HFE mutations and iron overload in patients with primary hypertriglyceridemia, a condition that is associated with NAFLD [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/61\">",
"       61",
"      </a>",
"      ]. However, another report found no association between the presence of an HFE mutation or a specific HFE genotype with the severity of hepatic fibrosis in patients with NAFLD [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased parenchymal hepatic iron concentration in NASH appears to correlate with the severity of fibrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/62,63\">",
"       62,63",
"      </a>",
"      ]. A study of 840 patients with NAFLD demonstrated that the pattern of iron staining correlated with the severity of histological injury [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/64\">",
"       64",
"      </a>",
"      ]. Among the 35 percent of patients with NAFLD who had stainable hepatic iron, those with a reticuloendothelial system (RES) cell pattern of iron staining were more likely to have portal inflammation, hepatocellular ballooning, definite steatohepatitis, and fibrosis. Patients with RES iron were also significantly more likely to have advanced fibrosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The specific mechanism by which hepatic iron may contribute to necroinflammation is unknown, but may be related to the generation of free oxygen radical species that occurs in the process of reduction of Fe 3+ to Fe 2+ [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/65\">",
"     65",
"    </a>",
"    ]. In one study, iron, even at normal levels, was an important factor in determining sensitivity to insulin [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/38\">",
"     38",
"    </a>",
"    ]. In addition, compared with glucose intolerant patients without fatty liver disease, glucose intolerant patients with fatty liver disease were 2.5 times more hyperinsulinemic at baseline. In those with fatty liver disease, both hyperinsulinemia and aminotransferase elevations were exceptionally responsive to iron depletion, even though all of the patients had normal iron indices. Interestingly, the glucose intolerant patients without fatty liver disease did not demonstrate significant improvements in fasting insulin levels after phlebotomy.",
"   </p>",
"   <p>",
"    Still unexplained is the observation that homozygosity for the hemochromatosis gene mutation does not appear to confer an increased risk for the development of NAFLD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/66\">",
"     66",
"    </a>",
"    ]. Furthermore, the clinical significance of iron overload in NASH with respect to clinically relevant endpoints is unclear. In an unselected cohort of 65 patients with NASH, iron accumulation was not associated with increased overall mortality, liver-related mortality, or development of cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     LEPTIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leptin is a peptide produced primarily in adipose tissue. An absence of leptin is associated with massive obesity in mice",
"    <span class=\"nowrap\">",
"     (ob/ob)",
"    </span>",
"    and in humans. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/50/13094?source=see_link\">",
"     \"Physiology of leptin\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Leptin may contribute to the development of fibrosis in NASH. Leptin induces dephosphorylation of insulin-receptor substrate 1, rendering hepatocytes more insulin-resistant [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/68\">",
"     68",
"    </a>",
"    ]. Blood leptin levels correlate with the degree of fibrosis in patients with chronic hepatitis C [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/69\">",
"     69",
"    </a>",
"    ], and leptin-deficient obese mice that are exposed to a methionine-choline-deficient diet, a necroinflammatory insult, do not develop hepatic fibrosis. Administration of leptin into the CNS of mice with fatty liver corrected insulin resistance and fatty liver, while peripheral administration did not [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/70\">",
"     70",
"    </a>",
"    ]. This suggests resistance to leptin in the CNS rather than the liver may be important in the pathogenesis of NASH. On the other hand, no relationship between leptin levels and fibrosis stage (after adjusting for potential confounders) was found in a study of 88 patients with NAFLD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ADIPONECTIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adiponectin is a hormone secreted exclusively by adipose tissue that produces beneficial effects on lipid metabolism, enhancing both lipid clearance from plasma and beta-oxidation of fatty acids in muscle [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/11\">",
"     11",
"    </a>",
"    ]. It also has direct anti-inflammatory effects, suppressing TNF-alpha production in the liver [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/11\">",
"     11",
"    </a>",
"    ]. In one report, low serum adiponectin levels correlated with the presence of NAFLD, hepatic fibrosis, and the severity of the metabolic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/72\">",
"     72",
"    </a>",
"    ]. Furthermore, adiponectin expression was markedly reduced in adipose tissue from",
"    <span class=\"nowrap\">",
"     ob/ob",
"    </span>",
"    (leptin-deficient) mice [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/11\">",
"     11",
"    </a>",
"    ]. A study in nonalcoholic obese",
"    <span class=\"nowrap\">",
"     ob/ob",
"    </span>",
"    mice demonstrated significant improvements in hepatic steatosis, hepatomegaly, and aminotransferase elevations following administration of adiponectin [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/11\">",
"     11",
"    </a>",
"    ]. Reduced circulating levels of adiponectin correlate with the severity of liver histology in NASH [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/73\">",
"     73",
"    </a>",
"    ]. Adiponectin appears to have a role in modulating insulin sensitivity. In one report, plasma adiponectin levels were significantly associated with hepatic insulin sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/74\">",
"     74",
"    </a>",
"    ]. Furthermore, administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/28/43463?source=see_link\">",
"     pioglitazone",
"    </a>",
"    increased adiponectin levels, which correlated with improvements in hepatic steatosis, necroinflammation, and fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/74,75\">",
"     74,75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     RESISTIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resistin is an adipose-derived protein that may have to an important physiological role in the development of insulin resistance. Overexpression of resistin in a mouse model led to glucose intolerance, hyperinsulinemia, and impaired suppression of free fatty acid levels [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/76\">",
"     76",
"    </a>",
"    ]. In addition, administering antisense oligonucleotides against resistin mRNA completely reversed the marked increase in resistin levels and severe insulin resistance that developed in mice fed high-fat diets [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     INTESTINAL MICROBES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intestinal microbes have been implicated as a potential source of hepatotoxic oxidative injury. In one report, small intestinal bacterial overgrowth was observed significantly more often in patients with NASH compared with controls [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/78\">",
"     78",
"    </a>",
"    ]. Another report found increased intestinal permeability in patients with NAFLD, possibly related to small intestinal bacterial overgrowth [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One proposed mechanism pertains to the production of endogenous alcohol and acetaldehyde [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/80\">",
"     80",
"    </a>",
"    ]. Colonic bacteria and yeast possess an enormous metabolic capacity for generating both ethanol and acetaldehyde, and can oxidize ethanol to high levels of acetaldehyde, even at low ethanol concentrations. Acetaldehyde is easily absorbed into the portal blood stream and can initiate histological changes similar to those seen in NAFLD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/81\">",
"     81",
"    </a>",
"    ]. High concentrations of endogenous alcohol production have been found in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/82\">",
"     82",
"    </a>",
"    ] and animals with intestinal blind-loops [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/83\">",
"     83",
"    </a>",
"    ]. Increased breath alcohol levels have been described in patients with Candida albicans overgrowth given a carbohydrate load and in obese females [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/84,85\">",
"     84,85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intestinal bacteria may also contribute to hepatic injury by means of endotoxin production. Rats injected with lipopolysaccharide develop steatohepatitis, while anti-TNF antibodies can improve steatosis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/86,87\">",
"     86,87",
"    </a>",
"    ]. Increased intestinal permeability and increased portal endotoxemia have been demonstrated in genetically obese mice, which are consistent with this theory [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. Significant increases in markers of intestinal permeability and a higher prevalence of small intestinal bacterial overgrowth have been demonstrated in humans with NAFLD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/79\">",
"     79",
"    </a>",
"    ]. These changes correlated with the severity of hepatic steatosis.",
"   </p>",
"   <p>",
"    Other possible mechanisms by which intestinal bacteria may contribute to hepatocellular injury include deconjugation of bile salts and inactivation of hepatic lipotropes, such as choline. Further supporting a pathogenic role for intestinal bacteria is the observation that the administration of antibiotics, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/20/17733?source=see_link\">",
"     polymyxin B",
"    </a>",
"    , improved steatosis grades in both rats and humans on TPN, and in alcohol exposed rats [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/90-92\">",
"     90-92",
"    </a>",
"    ]. In addition,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    administration improved hepatic steatosis following intestinal bypass surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/93\">",
"     93",
"    </a>",
"    ]. Finally, the administration of probiotics to mice with NAFLD led to improvements in steatosis, hepatomegaly, and NF-kB activity after four weeks of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     OTHER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obstructive sleep apnea has been proposed to have a role in inducing inflammation in NAFLD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/95\">",
"     95",
"    </a>",
"    ]. Compared with controls, mice on a high-fat, high-cholesterol diet exposed to six months of chronic intermittent hypoxia exhibited histological signs of liver injury, including lobular inflammation and fibrosis. Also noted were significant increases in hepatic lipid peroxidation and levels of proinflammatory cytokines. An observational study in obese patients undergoing gastric bypass surgery found that patients with higher oxygen desaturation index scores (number of drops in oxygen saturation of 3 percent per hour) had more severe histopathologic changes on liver biopsy than patients with lower oxygen desaturation index scores [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dietary cholesterol may also be an independent factor in the development of hepatic inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/97\">",
"     97",
"    </a>",
"    ]. Hyperlipidemic mice fed high-fat diets with cholesterol developed steatosis with severe inflammation, compared with normolipidemic control animals that developed only steatosis. Hepatic inflammation was linked to increased plasma very low-density lipoprotein (VLDL) cholesterol levels. Omitting cholesterol and lowering VLDL levels prevented hepatic inflammation. On the cellular level, activation of the nuclear receptor constitutive androstane receptor (CAR) is important in the development of lipid peroxidation and steatohepatitis. In a dietary model of NASH, activation of the CAR receptor resulted in hepatic inflammation and fibrosis, in contrast to increased steatosis alone in CAR negative animals [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     FIBROSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perisinusoidal (zone 3) fibrosis in patients with NASH is primarily a consequence of the chronic inflammatory process with activation of lobular stellate cells. Portal fibrosis is commonly a feature of progressive disease. It stems from the activation of a secondary replicative pathway involving hepatic progenitor cells (HPCs) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/99\">",
"     99",
"    </a>",
"    ]. HPCs appear to proliferate in the setting of primary replicative senescence from chronic hepatocyte injury. A ductular reaction ensues, leading to periportal fibrogenesis. Increases in the ductular correlated with the grade of NASH activity, the degree of fibrosis, and the extent of primary hepatocyte replicative arrest, which in turn correlated with insulin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16073/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disorders that range from simple hepatic steatosis without significant inflammation or fibrosis to nonalcoholic steatohepatitis with varying degrees of inflammation and fibrosis.",
"     </li>",
"     <li>",
"      Strong epidemiological, biochemical, and therapeutic evidence supports the premise that the primary pathophysiological derangement in most patients with NAFLD is insulin resistance. Insulin resistance leads to increased lipolysis, triglyceride synthesis, increased hepatic uptake of free fatty acids, and accumulation of hepatic triglyceride. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Insulin resistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several fat derived hormones, such as adiponectin, leptin, and resistin, are important regulators of hepatic insulin sensitivity. At the cellular level, these effects appear to be modulated through altered activation of numerous receptors, membrane glycoproteins, and cytokines.",
"     </li>",
"     <li>",
"      Factors that determine the presence and extent of necroinflammation are not yet well understood. Several possible mechanisms have been theorized, including host factors, such as defects in mitochondrial structure and function, impaired free oxygen radical scavenging, increased hepatic iron, and hepatotoxic byproducts of intestinal bacteria.",
"     </li>",
"     <li>",
"      The factors involved in hepatic fibrogenesis are slowly becoming understood. Activation of both lobular stellate cells and hepatic progenitor cells has been observed in NAFLD. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Fibrosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H116028719\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the death of Marshall M. Kaplan, MD, who passed away in September 2012. UpToDate wishes to acknowledge Dr. Kaplan's many contributions to our program, in particular, his work on this topic as our Section Editor for Alcoholic and Metabolic Liver Disease.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/1\">",
"      Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/2\">",
"      Caldwell SH, Oelsner DH, Iezzoni JC, et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/3\">",
"      Donnelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/4\">",
"      Musso G, Gambino R, De Michieli F, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003; 37:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/5\">",
"      Lett&eacute;ron P, Sutton A, Mansouri A, et al. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology 2003; 38:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/6\">",
"      Huang J, Iqbal J, Saha PK, et al. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology 2007; 46:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/7\">",
"      Fujita K, Nozaki Y, Wada K, et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology 2009; 50:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/8\">",
"      Kajikawa S, Harada T, Kawashima A, et al. Highly purified eicosapentaenoic acid ethyl ester prevents development of steatosis and hepatic fibrosis in rats. Dig Dis Sci 2010; 55:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/9\">",
"      Ip E, Farrell GC, Robertson G, et al. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 2003; 38:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/10\">",
"      Cortez-Pinto H, Chatham J, Chacko VP, et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999; 282:1659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/11\">",
"      Xu A, Wang Y, Keshaw H, et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003; 112:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/12\">",
"      Gary-Bobo M, Elachouri G, Gallas JF, et al. Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology 2007; 46:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/13\">",
"      Villanueva CJ, Monetti M, Shih M, et al. Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids. Hepatology 2009; 50:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/14\">",
"      Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases. World J Gastroenterol 2009; 15:5633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/15\">",
"      Hand NJ, Master ZR, Le Lay J, Friedman JR. Hepatic function is preserved in the absence of mature microRNAs. Hepatology 2009; 49:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/16\">",
"      Jin X, Ye YF, Chen SH, et al. MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease. Dig Liver Dis 2009; 41:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/17\">",
"      Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/18\">",
"      Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/19\">",
"      Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/20\">",
"      Willner IR, Waters B, Patil SR, et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 2001; 96:2957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/21\">",
"      Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002; 35:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/22\">",
"      Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/23\">",
"      Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/24\">",
"      Marchesini G, Brizi M, Bianchi G, et al. Metformin in non-alcoholic steatohepatitis. Lancet 2001; 358:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/25\">",
"      Marchesini G, Pagotto U, Bugianesi E, et al. Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. J Clin Endocrinol Metab 2003; 88:5674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/26\">",
"      Kim HJ, Kim HJ, Lee KE, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004; 164:2169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/27\">",
"      Petersen KF, Dufour S, Hariri A, et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 2010; 362:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/28\">",
"      Carulli L, Canedi I, Rondinella S, et al. Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis. Dig Liver Dis 2009; 41:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/29\">",
"      Rotman Y, Koh C, Zmuda JM, et al. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010; 52:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/30\">",
"      Sookoian S, Rosselli MS, Gemma C, et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor &gamma; coactivator 1&alpha; promoter. Hepatology 2010; 52:1992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/31\">",
"      Gastaldelli A, Cusi K, Pettiti M, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 2007; 133:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/32\">",
"      van der Poorten D, Milner KL, Hui J, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008; 48:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/33\">",
"      Wieckowska A, Papouchado BG, Li Z, et al. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol 2008; 103:1372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/34\">",
"      Calvert VS, Collantes R, Elariny H, et al. A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. Hepatology 2007; 46:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/35\">",
"      Fiorentino L, Vivanti A, Cavalera M, et al. Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology 2010; 51:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/36\">",
"      Ryan MW, Harrison SA, Neuschwander-Tetri BA. Serum amyloid A and C-reactive protein diminish after treatment of NASH with rosiglitazone (abstract). Gastroenterology 2003; 124A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/37\">",
"      Gastaldelli A, Harrison SA, Belfort-Aguilar R, et al. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 2009; 50:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/38\">",
"      Facchini FS, Hua NW, Stoohs RA. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 2002; 122:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/39\">",
"      Kelley DE, McKolanis TM, Hegazi RA, et al. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003; 285:E906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/40\">",
"      Kral JG, Lundholm K, Bj&ouml;rntorp P, et al. Hepatic lipid metabolism in severe human obesity. Metabolism 1977; 26:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/41\">",
"      Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983; 72:1737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/42\">",
"      Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/43\">",
"      Sreekumar R, Rosado B, Rasmussen D, Charlton M. Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology 2003; 38:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/44\">",
"      Hruszkewycz AM. Evidence for mitochondrial DNA damage by lipid peroxidation. Biochem Biophys Res Commun 1988; 153:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/45\">",
"      Chen J, Schenker S, Frosto TA, Henderson GI. Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits. Biochim Biophys Acta 1998; 1380:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/46\">",
"      Rensen SS, Slaats Y, Driessen A, et al. Activation of the complement system in human nonalcoholic fatty liver disease. Hepatology 2009; 50:1809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/47\">",
"      Rensen SS, Slaats Y, Nijhuis J, et al. Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol 2009; 175:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/48\">",
"      Tajiri K, Shimizu Y, Tsuneyama K, Sugiyama T. Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2009; 21:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/49\">",
"      Sastre J, Pallard&oacute; FV, Llopis J, et al. Glutathione depletion by hyperphagia-induced obesity. Life Sci 1989; 45:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/50\">",
"      Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 2000; 136:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/51\">",
"      Baskol G, Baskol M, Kocer D. Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. Clin Biochem 2007; 40:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/52\">",
"      Yu J, Chu ES, Wang R, et al. Heme oxygenase-1 protects against steatohepatitis in both cultured hepatocytes and mice. Gastroenterology 2010; 138:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/53\">",
"      Ikura Y, Ohsawa M, Suekane T, et al. Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. Hepatology 2006; 43:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/54\">",
"      Nocito A, Dahm F, Jochum W, et al. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Gastroenterology 2007; 133:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/55\">",
"      Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000; 136:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/56\">",
"      Harrison SA, Torgerson S, Hayashi P, et al. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003; 98:2485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/57\">",
"      Ma X, Hua J, Mohamood AR, et al. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 2007; 46:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/58\">",
"      Mendler MH, Turlin B, Moirand R, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/59\">",
"      Vigan&ograve; M, Vergani A, Trombini P, et al. Insulin resistance influence iron metabolism and hepatic steatosis in type II diabetes. Gastroenterology 2000; 118:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/60\">",
"      Bonkovsky HL, Jawaid Q, Tortorelli K, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999; 31:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/61\">",
"      Solanas-Barca M, Mateo-Gallego R, Calmarza P, et al. Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia. J Clin Endocrinol Metab 2009; 94:4391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/62\">",
"      Valenti L, Fracanzani AL, Bugianesi E, et al. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 2010; 138:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/63\">",
"      George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/64\">",
"      Nelson JE, Wilson L, Brunt EM, et al. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology 2011; 53:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/65\">",
"      Woods JR Jr, Plessinger MA, Fantel A. An introduction to reactive oxygen species and their possible roles in substance abuse. Obstet Gynecol Clin North Am 1998; 25:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/66\">",
"      Chitturi S, Weltman M, Farrell GC, et al. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 2002; 36:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/67\">",
"      Younossi ZM, Gramlich T, Bacon BR, et al. Hepatic iron and nonalcoholic fatty liver disease. Hepatology 1999; 30:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/68\">",
"      Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/69\">",
"      Crespo J, Rivero M, F&aacute;brega E, et al. Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis. Dig Dis Sci 2002; 47:1604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/70\">",
"      Asilmaz E, Cohen P, Miyazaki M, et al. Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest 2004; 113:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/71\">",
"      Angulo P, Alba LM, Petrovic LM, et al. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol 2004; 41:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/72\">",
"      Savvidou S. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD. J Clin Gastroenterology 2009; 43:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/73\">",
"      Musso G, Gambino R, Durazzo M, et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005; 42:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/74\">",
"      Gastaldelli A, Harrison S, Belfort-Aguiar R, et al. Pioglitazone in the treatment of NASH: the role of adiponectin. Aliment Pharmacol Ther 2010; 32:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/75\">",
"      Leclercq IA, Lebrun VA, St&auml;rkel P, Horsmans YJ. Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone. Lab Invest 2007; 87:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/76\">",
"      Satoh H, Nguyen MT, Miles PD, et al. Adenovirus-mediated chronic \"hyper-resistinemia\" leads to in vivo insulin resistance in normal rats. J Clin Invest 2004; 114:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/77\">",
"      Muse ED, Obici S, Bhanot S, et al. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004; 114:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/78\">",
"      Wigg AJ, Roberts-Thomson IC, Dymock RB, et al. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001; 48:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/79\">",
"      Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009; 49:1877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/80\">",
"      Cope K, Risby T, Diehl AM. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 2000; 119:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/81\">",
"      Salaspuro M. Bacteriocolonic pathway for ethanol oxidation: characteristics and implications. Ann Med 1996; 28:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/82\">",
"      Mezey E, Imbembo AL, Potter JJ, et al. Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity. Am J Clin Nutr 1975; 28:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/83\">",
"      Baraona E, Julkunen R, Tannenbaum L, Lieber CS. Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats. Gastroenterology 1986; 90:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/84\">",
"      Kaji H, Asanuma Y, Yahara O, et al. Intragastrointestinal alcohol fermentation syndrome: report of two cases and review of the literature. J Forensic Sci Soc 1984; 24:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/85\">",
"      Nair S, Cope K, Risby TH, et al. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol 2001; 96:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/86\">",
"      Pappo I, Bercovier H, Berry E, et al. Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat. JPEN J Parenter Enteral Nutr 1995; 19:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/87\">",
"      Kirsch R, Clarkson V, Verdonk RC, et al. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. J Gastroenterol Hepatol 2006; 21:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/88\">",
"      Brun P, Castagliuolo I, Di Leo V, et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292:G518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/89\">",
"      Jin X, Yu CH, Lv GC, Li YM. Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats. World J Gastroenterol 2007; 13:1732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/90\">",
"      Enomoto N, Yamashina S, Kono H, et al. Development of a new, simple rat model of early alcohol-induced liver injury based on sensitization of Kupffer cells. Hepatology 1999; 29:1680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/91\">",
"      Pappo I, Bercovier H, Berry EM, et al. Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide. JPEN J Parenter Enteral Nutr 1992; 16:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/92\">",
"      Pappo I, Becovier H, Berry EM, Freund HR. Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat. J Surg Res 1991; 51:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/93\">",
"      Drenick EJ, Fisler J, Johnson D. Hepatic steatosis after intestinal bypass--prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition. Gastroenterology 1982; 82:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/94\">",
"      Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003; 37:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/95\">",
"      Zamora-Vald&eacute;s D, M&eacute;ndez-S&aacute;nchez N. Experimental evidence of obstructive sleep apnea syndrome as a second hit accomplice in nonalcoholic steatohepatitis pathogenesis. Ann Hepatol 2007; 6:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/96\">",
"      Aron-Wisnewsky J, Minville C, Tordjman J, et al. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol 2012; 56:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/97\">",
"      Wouters K, van Gorp PJ, Bieghs V, et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 2008; 48:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/98\">",
"      Yamazaki Y, Kakizaki S, Horiguchi N, et al. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis. Gut 2007; 56:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16073/abstract/99\">",
"      Richardson MM, Jonsson JR, Powell EE, et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007; 133:80.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3596 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-8E53C3882F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16073=[""].join("\n");
var outline_f15_44_16073=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CAUSES OF TRIGLYCERIDE ACCUMULATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INSULIN RESISTANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H366045064\">",
"      HEPATOCELLULAR INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ANTIOXIDANTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      IRON",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      LEPTIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ADIPONECTIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      RESISTIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      INTESTINAL MICROBES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      OTHER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      FIBROSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H116028719\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38105?source=related_link\">",
"      Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23882?source=related_link\">",
"      Natural history and management of nonalcoholic fatty liver disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/31/36346?source=related_link\">",
"      Pathogenesis of type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/50/13094?source=related_link\">",
"      Physiology of leptin",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_44_16074="Bronchiolitis in infants and children: Clinical features and diagnosis";
var content_f15_44_16074=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bronchiolitis in infants and children: Clinical features and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/44/16074/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16074/contributors\">",
"     Pedro A Piedra, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16074/contributors\">",
"     Ann R Stark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/44/16074/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16074/contributors\">",
"     Gregory Redding, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16074/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/44/16074/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/44/16074/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/44/16074/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchiolitis, a lower respiratory tract infection that primarily affects the small airways (bronchioles), is a common cause of illness and hospitalization in infants and young children.",
"   </p>",
"   <p>",
"    The microbiology, epidemiology, clinical features, and diagnosis of bronchiolitis will be presented here. The treatment, outcome, and prevention of bronchiolitis in children; respiratory syncytial virus, and the emergent evaluation of children with acute respiratory distress are discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/19/27962?source=see_link\">",
"       \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link\">",
"       \"Respiratory syncytial virus infection: Clinical features and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/27/38327?source=see_link\">",
"       \"Respiratory syncytial virus infection: Treatment\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=see_link\">",
"       \"Respiratory syncytial virus infection: Prevention\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/61/7130?source=see_link\">",
"       \"Emergent evaluation of acute respiratory compromise in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchiolitis is broadly defined as a clinical syndrome that occurs in children &lt;2 years of age and is characterized by upper respiratory symptoms (eg, rhinorrhea) followed by lower respiratory infection with inflammation, which results in wheezing and or crackles (rales). Bronchiolitis typically occurs with primary infection or reinfection with a viral pathogen [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. In young children, the clinical diagnosis of bronchiolitis may overlap with recurrent virus-induced wheezing and acute viral-triggered asthma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/15/2298?source=see_link\">",
"     \"Virus-induced wheezing and asthma: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For clinical research, bronchiolitis is typically defined as the first episode of wheezing in a child younger than 12 to 24 months who has physical findings of a viral lower respiratory infection and no other explanation for the wheezing [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H70679837\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchiolitis occurs when viruses infect the terminal bronchiolar epithelial cells, causing direct damage and inflammation in the small bronchi and bronchioles. Edema, excessive mucus, and sloughed epithelial cells lead to obstruction of small airways and atelectasis. Based upon biopsy or autopsy samples in severe cases and animal studies, pathologic changes begin 18 to 24 hours after infection and include bronchiolar cell necrosis, ciliary disruption, and peribronchiolar lymphocytic infiltration [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchiolitis typically is caused by a viral infection. Although the proportion of disease caused by specific viruses varies depending upon the season and the year, respiratory syncytial virus (RSV) is the most common cause, followed by rhinovirus [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. Less common causes include parainfluenza virus, human metapneumovirus, influenza virus, adenovirus, coronavirus, and human bocavirus [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. With molecular diagnostics, two or more viruses are detected in approximately one-third of young children hospitalized with bronchiolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/10,15-17\">",
"     10,15-17",
"    </a>",
"    ]. In addition, lower respiratory tract infection and wheezing episodes in infants occasionally are associated with",
"    <em>",
"     Mycoplasma pneumoniae",
"    </em>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6713?source=see_link&amp;anchor=H5#H5\">",
"     \"Mycoplasma pneumoniae infection in children\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      RSV &ndash; RSV is the most common cause of bronchiolitis and the virus most often detected as the sole pathogen. RSV is ubiquitous throughout the world and causes seasonal outbreaks. In temperate climates, late fall and winter epidemics of bronchiolitis usually are linked to RSV. In tropical and semitropical climates, the seasonal outbreaks usually are associated with the rainy season. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link\">",
"       \"Respiratory syncytial virus infection: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rhinovirus &ndash; Human rhinoviruses are the main cause of the common cold. There are more than 100 serotypes. Rhinovirus is associated with lower respiratory tract infection in young children and in individuals with chronic pulmonary disease [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/18\">",
"       18",
"      </a>",
"      ]. Dual viral infections are often detected. Rhinovirus is often associated with bronchiolitis in the spring and fall [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/19\">",
"       19",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19383?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Parainfluenza virus &ndash; Parainfluenza virus type 3, which is associated with epidemics in early spring and fall, is another cause of bronchiolitis. Parainfluenza virus types 1 and 2 also can cause bronchiolitis although croup is the more common presentation [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36808?source=see_link&amp;anchor=H10#H10\">",
"       \"Parainfluenza viruses in children\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Human metapneumovirus &ndash; Human metapneumovirus sometimes occurs in conjunction with other viral infections and has been identified as an etiology of bronchiolitis and pneumonia in children [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33304?source=see_link\">",
"       \"Human metapneumovirus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Influenza virus &ndash; The lower respiratory tract manifestations of influenza are clinically indistinguishable from those due to RSV or parainfluenza viral infections. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical features and diagnosis of seasonal influenza in children\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Adenovirus &ndash; Adenovirus may cause lower respiratory tract infections, including bronchiolitis, bronchiolitis obliterans, and pneumonia, though it more typically causes pharyngitis and coryza. Adenovirus can also infect other organs causing disseminated disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=see_link&amp;anchor=H9#H9\">",
"       \"Epidemiology and clinical manifestations of adenovirus infection\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Coronavirus &ndash; Human coronaviruses are another important cause of the common cold, which can also cause lower respiratory tract infection, including bronchiolitis [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/23,24\">",
"       23,24",
"      </a>",
"      ]. Severe acute respiratory syndrome (SARS) was caused by a coronavirus that likely originated from the Chinese horseshoe bat [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/25\">",
"       25",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41176?source=see_link\">",
"       \"Coronaviruses\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Human bocavirus &ndash; Human bocavirus 1 causes upper and lower respiratory infections during the fall and winter months [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/13,26-28\">",
"       13,26-28",
"      </a>",
"      ]. Bronchiolitis and pertussis-like illness can occur. Human bocavirus 2 through 4 are primarily enteric viruses [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchiolitis typically affects infants and children younger than two years, principally during the fall and winter [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/30\">",
"     30",
"    </a>",
"    ]. Bronchiolitis hospitalization has a peak incidence between two and six months of age and remains a significant cause of respiratory disease during the first five years of life [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/31\">",
"     31",
"    </a>",
"    ]. It is a leading cause of hospitalization in infants and young children [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology of bronchiolitis is similar to that of respiratory syncytial virus (RSV) infection because most cases of bronchiolitis are caused by RSV. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H2#H2\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H70682711\">",
"    <span class=\"h1\">",
"     RISK FACTORS FOR SEVERE DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for severe or complicated bronchiolitis include [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/33-38\">",
"     33-38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prematurity (gestational age &lt;37 weeks)",
"     </li>",
"     <li>",
"      Age less than 12 weeks",
"     </li>",
"     <li>",
"      Chronic pulmonary disease, particularly bronchopulmonary dysplasia (also known as chronic lung disease)",
"     </li>",
"     <li>",
"      Congenital and anatomic defects of the airways",
"     </li>",
"     <li>",
"      Congenital heart disease",
"     </li>",
"     <li>",
"      Immunodeficiency",
"     </li>",
"     <li>",
"      Neurologic disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Environmental and other risk factors, such as passive smoking, crowded household, daycare attendance, concurrent birth siblings, older siblings, and high altitude (&gt;2500 meters) can also contribute to more severe disease [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/38-42\">",
"     38-42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H58735788\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with moderate to severe bronchiolitis typically present for medical attention three to six days after illness onset. Bronchiolitis often is preceded by a one- to three-day history of upper respiratory tract symptoms, such as nasal congestion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    discharge and mild cough [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/43\">",
"     43",
"    </a>",
"    ]. It typically presents with fever (usually &le;38.3&ordm;C), cough, and mild respiratory distress (eg, mildly increased respiratory rate, mild retractions).",
"   </p>",
"   <p>",
"    Compared with other viruses that cause bronchiolitis, fever tends to be lower with respiratory syncytial virus (RSV) and higher with adenovirus [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H15#H15\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology and clinical manifestations of adenovirus infection\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Aspects of the history that help in determining the severity of illness",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    need for hospitalization include (see",
"    <a class=\"local\" href=\"#H70680853\">",
"     'Severity assessment'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/19/27962?source=see_link&amp;anchor=H162664498#H162664498\">",
"     \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\", section on 'Indications for hospitalization'",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Assessment of hydration status (eg, fluid intake, urine output)",
"     </li>",
"     <li>",
"      Symptoms of respiratory distress (tachypnea, nasal flaring, retractions, grunting)",
"     </li>",
"     <li>",
"      Cyanosis",
"     </li>",
"     <li>",
"      Episodes of restlessness or lethargy (may indicate hypoxemia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      impending respiratory failure)",
"     </li>",
"     <li>",
"      A history of apnea with cyanosis or bradycardia",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Characteristic examination findings of bronchiolitis include tachypnea, mild intercostal and subcostal retractions, and expiratory wheezing. Additional auscultatory findings may include prolonged expiratory phase and coarse or fine crackles (rales). The chest may appear hyperexpanded with increased anteroposterior diameter and may be hyperresonant to percussion. Mild hypoxemia (oxygen saturation &lt;95 percent) commonly is detected by pulse oximetry. Other findings may include mild conjunctivitis, pharyngitis, and acute otitis media (in approximately one-half of patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/45-47\">",
"     45-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Severely affected patients have increased work of breathing (subcostal, intercostal, and supraclavicular retractions; nasal flaring; and expiratory grunting). They may appear cyanotic and have poor peripheral perfusion. Wheezing may not be audible if the airways are profoundly narrowed or when increased work of breathing results in exhaustion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H317309589\">",
"    <span class=\"h2\">",
"     Comorbid serious bacterial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serious comorbid infection is rare in children with bronchiolitis. In prospective studies, the risk for bacteremia or meningitis among febrile infants and young children with bronchiolitis is typically less than 1 to 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/48-51\">",
"     48-51",
"    </a>",
"    ]. The risk for urinary tract infection (UTI), which ranges from 1 to 5 percent, is less than that for febrile infants without bronchiolitis (approximately 10 to 20 percent, depending on age, sex, circumcision status, etc), though it is not negligible. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28951?source=see_link&amp;anchor=H13#H13\">",
"     \"Definition and etiology of fever in neonates and infants (less than three months of age)\", section on 'Sources of infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H155909997\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographs are not routinely indicated in the evaluation of infants and children with bronchiolitis. The radiographic abnormalities of bronchiolitis are variable and nonspecific [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. They include hyperinflation and peribronchial thickening (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef88283 \" href=\"UTD.htm?12/17/12561\">",
"     image 1",
"    </a>",
"    ). Patchy atelectasis with volume loss may result from airway narrowing and mucus plugging.",
"   </p>",
"   <p>",
"    Segmental consolidation and alveolar infiltrates are more characteristic of bacterial pneumonia than bronchiolitis, but radiographic findings are poor indicators of the etiologic diagnosis and must be used in conjunction with other clinical features in making decisions about diagnosis and treatment. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Differential diagnosis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical features and diagnosis of community-acquired pneumonia in children\", section on 'Etiologic clues'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     CLINICAL COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of the illness due to bronchiolitis depends upon age, severity of illness, associated high-risk conditions (eg, prematurity, chronic pulmonary disease), and the causative agent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/10\">",
"     10",
"    </a>",
"    ]. Bronchiolitis usually is a self-limited disease. Most children who do not require hospitalization recover by 28 days [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/54-56\">",
"     54-56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Typical illness with bronchiolitis begins with upper respiratory tract symptoms, followed by lower respiratory tract signs and symptoms on days two to three, which peak on days five to seven and then gradually resolve. In a cohort of 181 children, the median duration of caretaker-reported symptoms was 12 days [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/54\">",
"     54",
"    </a>",
"    ]. Approximately 20 percent continued to have symptoms for at least three weeks, and 10 percent had symptoms for at least four weeks.",
"   </p>",
"   <p>",
"    In previously healthy infants older than six months who require hospitalization, the average length of hospitalization is three to four days, although it may be longer in children with bronchiolitis due to rhinovirus [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/10,31\">",
"     10,31",
"    </a>",
"    ]. The respiratory status typically improves over two to five days [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/34,57-60\">",
"     34,57-60",
"    </a>",
"    ]. However, wheezing persists in some infants for a week or longer.",
"   </p>",
"   <p>",
"    The course may be prolonged in infants younger than six months (particularly those younger than 12 weeks) and those with comorbid conditions (eg, bronchopulmonary dysplasia); these children often are severely affected and may require assisted ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/33,61\">",
"     33,61",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H70682711\">",
"     'Risk factors for severe disease'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H19\">",
"     'Respiratory failure'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most previously healthy infants, bronchiolitis resolves without complications. However, severely affected patients, particularly those born prematurely, &lt;12 weeks of age, or who have underlying cardiopulmonary disease or immunodeficiency, are at increased risk for complications, the most serious of which are apnea and respiratory failure [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/62\">",
"     62",
"    </a>",
"    ]. Infants who require mechanical ventilation for apnea or respiratory failure may develop air leak, such as pneumothorax or pneumomediastinum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H70684147\">",
"    <span class=\"h2\">",
"     Dehydration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with bronchiolitis may have difficulty maintaining adequate hydration because of increased fluid needs (related to fever and tachypnea), decreased oral intake (related to tachypnea and respiratory distress),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vomiting [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/63\">",
"     63",
"    </a>",
"    ]. They should be monitored for dehydration (eg, increased heart rate, dry mucosa, sunken fontanelle, decreased urine output (",
"    <a class=\"graphic graphic_table graphicRef76198 \" href=\"UTD.htm?13/5/13404\">",
"     table 1",
"    </a>",
"    )). Parenteral fluid administration may be necessary. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3607?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical assessment and diagnosis of hypovolemia (dehydration) in children\", section on 'Clinical assessment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/19/27962?source=see_link&amp;anchor=H403689557#H403689557\">",
"     \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\", section on 'Fluid administration'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchiolitis may be complicated by apnea, particularly in infants born prematurely and those younger than two months (ie, those with postmenstrual age &lt;48 weeks) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/62,64-67\">",
"     62,64-67",
"    </a>",
"    ]. RSV may cause significant apnea, even in infants without signs of bronchiolitis. The mechanism is not known. Presenting with apnea is a risk factor for respiratory failure and the need for mechanical ventilation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H16#H16\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Apnea'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H19\">",
"     'Respiratory failure'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The magnitude of the risk of apnea among infants with bronchiolitis is poorly quantified. Prospective studies are lacking. In a multicenter study, apnea occurred during hospitalization in 9 percent of 684 infants &lt;12 months who were hospitalized with bronchiolitis or RSV pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/62\">",
"     62",
"    </a>",
"    ]. In a 2009 systematic review of studies of infants hospitalized with RSV bronchiolitis (but not bronchiolitis due to other viruses), the incidence of apnea ranged from 1.2 to 23.8 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for apnea in infants &lt;6 months of age were evaluated in a retrospective cohort of 691 infants who were hospitalized for bronchiolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/67\">",
"     67",
"    </a>",
"    ]. Apnea developed during hospitalization in 3 percent. All of the infants who developed apnea during hospitalization had a history of apnea witnessed by parent or clinician before admission to the hospital or were young (younger than one month for full-term infants or less than 48 weeks' postmenstrual age for infants born at &lt;37 weeks gestation); however only 7 percent of children with these risk factors developed apnea during hospitalization. No patient classified as low risk subsequently developed apnea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Respiratory failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory failure is another serious complication of bronchiolitis. In a multicenter study, respiratory failure occurred in 14 percent of 684 infants younger than 12 months who were hospitalized for management of bronchiolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/62\">",
"     62",
"    </a>",
"    ]. In another multicenter study, 16 percent of infants hospitalized with RSV required intensive care support (with or without mechanical ventilation) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/34\">",
"     34",
"    </a>",
"    ]. However, the need for intensive care varied depending on the presence and type of risk factors for serious disease:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      No known risk factors &ndash; 7 percent",
"     </li>",
"     <li>",
"      Congenital heart disease, bronchopulmonary dysplasia, or immunosuppression &ndash; 19 to 37 percent",
"     </li>",
"     <li>",
"      Age &lt;6 weeks &ndash; 29 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hypoxemia, associated with mucus plugging and atelectasis, is common in children with bronchiolitis. It may respond to supplemental oxygen alone, although sometimes it requires additional respiratory support. Hypercapnic respiratory failure, associated with fatigue, usually requires additional respiratory support (eg, intubation and mechanical ventilation).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Secondary bacterial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the exception of otitis media, secondary bacterial infection is uncommon among infants and young children with bronchiolitis or RSV infection. In a nine-year prospective study of 565 children (&lt;3 years) hospitalized with documented RSV infection, subsequent bacterial infection developed only 1.2 percent and subsequent bacterial pneumonia in 0.9 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/69\">",
"     69",
"    </a>",
"    ]. The risk of secondary bacterial pneumonia is increased among children who require admission to the intensive care unit, particularly those who require intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/70,71\">",
"     70,71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Clinical diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchiolitis is diagnosed clinically. Characteristic features include a viral upper respiratory prodrome followed by increased respiratory effort (eg, tachypnea, nasal flaring, chest retractions) and wheezing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    rales in children younger than two years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H58735788\">",
"     'History'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H9\">",
"     'Examination'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Chest radiographs and laboratory studies are not necessary to make the diagnosis of bronchiolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1\">",
"     1",
"    </a>",
"    ]. However, they may support the diagnosis and may be necessary to assess the severity of illness, evaluate potential complications, or exclude other conditions in the differential diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/2,72\">",
"     2,72",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H70680853\">",
"     'Severity assessment'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H17\">",
"     'Complications'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H28\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H58728348\">",
"    <span class=\"h2\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest radiographs are not necessary in the routine evaluation of bronchiolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. In infants and young children with mild disease, radiographs are unlikely to alter treatment and may lead to inappropriate use of antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1,3,52,73\">",
"     1,3,52,73",
"    </a>",
"    ]. Chest radiographs should not be routinely obtained in the absence of clinical findings suggestive of other diagnostic suspicions [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    However, in infants and young children with moderate or severe respiratory distress (eg, nasal flaring, retractions, grunting, respiratory rate &gt;70 breaths per minute, dyspnea, or cyanosis), radiographs usually are indicated, particularly if there are focal findings on examination, the infant has a cardiac murmur, or it is necessary to exclude alternate diagnoses [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. Radiographs also may be indicated to exclude alternate diagnoses in children who fail to improve at the expected rate [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H70680853\">",
"     'Severity assessment'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H28\">",
"     'Differential diagnosis'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H16\">",
"     'Clinical course'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Radiographic features of bronchiolitis, which are variable and nonspecific, include hyperinflation and peribronchial thickening (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef88283 \" href=\"UTD.htm?12/17/12561\">",
"     image 1",
"    </a>",
"    ). Patchy atelectasis with volume loss may result from airway narrowing and mucus plugging. (See",
"    <a class=\"local\" href=\"#H155909997\">",
"     'Radiographic features'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H317309641\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Virologic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do not routinely suggest testing for specific viral agents in children with bronchiolitis unless the results of such testing will alter management of the patient or patient&rsquo;s contacts (eg, initiation or",
"    <span class=\"nowrap\">",
"     continuation/discontinuation",
"    </span>",
"    of antibiotic therapy, anti-influenza therapy, anti-influenza prophylaxis for high risk contacts, or cohorting of hospitalized patients or caregivers) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/2,74\">",
"     2,74",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26746?source=see_link&amp;anchor=H20#H20\">",
"     \"Antiviral drugs for the prevention and treatment of seasonal influenza in children\", section on 'Antiviral therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is debate about whether testing for specific viral agents alters clinical management or outcome, particularly in the outpatient setting [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1,2,72,74-77\">",
"     1,2,72,74-77",
"    </a>",
"    ]. However, the identification of a viral etiologic agent during emergency department evaluation or in hospitalized patients has been associated with a decreased utilization of antibiotic treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/76,78-80\">",
"     76,78-80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Identification of the responsible virus in hospitalized patients may help to avoid nosocomial transmission by permitting cohorting of patients",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    caregivers. However, direct evidence that this strategy prevents nosocomial transmission or respiratory viruses in children is lacking, and it may be more logical to isolate all infants with bronchiolitis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/2,81\">",
"     2,81",
"    </a>",
"    ]. Cohorting has the potential to increase the risk of infection with other respiratory viruses leading to prolonged hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=see_link&amp;anchor=H104278849#H104278849\">",
"     \"Respiratory syncytial virus infection: Prevention\", section on 'Nosocomial infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When an etiologic diagnosis is necessary (eg, for cohorting hospitalized patients or caregivers; if the results will affect other management decisions such as whether to initiate or continue antibiotic therapy), the recommended approach is screening by antigen detection or immunofluorescence of respiratory secretions obtained by nasal wash or nasal aspirate (rather than nasopharyngeal swabs) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/82,83\">",
"     82,83",
"    </a>",
"    ]. Rapid antigen tests are available for respiratory syncytial virus (RSV), parainfluenza, adenovirus, and influenza viruses. Direct or indirect immunofluorescence tests are available for these and other viruses that cause bronchiolitis. Culture and polymerase chain reaction (PCR) are additional methods that can be used for viral identification. The laboratory diagnosis depends upon the quality and proper handling of the specimen. The sensitivity of most rapid antigen tests ranges from 80 to 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nasal wash specimens are obtained by holding the infant or child upright at a 45&ordm; angle. A bulb syringe or a soft plastic catheter attached to suction is used to aspirate nasal secretions after a small amount of normal saline (1 to 3 mL) is instilled in each nostril.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H70680187\">",
"    <span class=\"h3\">",
"     Other laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory tests are not routinely indicated in the evaluation of infants and young children with suspected bronchiolitis. Data demonstrating the utility of complete blood counts (CBCs) in the diagnosis or management of bronchiolitis are lacking [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1,2,72,85\">",
"     1,2,72,85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, laboratory",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiographic evaluation may be necessary to evaluate the possibility of comorbid or secondary bacterial infection in young infants with suspected bronchiolitis and fever, complications, or other diagnostic considerations in children with an unusual clinical presentation or a severe",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    prolonged course of illness.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Neonates &le;28 days of age with fever",
"      </strong>",
"      &ndash; Infants &le;28 days old with fever (T &ge;38&ordm;C [100.4&ordm;F]) and symptoms and signs of bronchiolitis have the same risk for serious bacterial infection as young febrile infants without bronchiolitis and should be assessed accordingly [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/49\">",
"       49",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link\">",
"       \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Infants 28 to 90 days of age with fever",
"      </strong>",
"      &ndash; CBC, urinalysis, urine culture, and chest radiograph may be warranted to exclude comorbid or secondary bacterial infection in febrile (T &ge;38&ordm;C [100.4&ordm;F]) infants with symptoms and signs of bronchiolitis who are between 28 and 90 days of age. However, the yield of this evaluation is likely to be low. Although the CBC is often used to screen for serious bacterial infection in infants without bronchiolitis, in a large retrospective study, abnormal white blood cell count was not predictive of serious bacterial infection in infants and young children who were hospitalized with RSV [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/85\">",
"       85",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link&amp;anchor=H12#H12\">",
"       \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\", section on 'Evaluation and management'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H317309589\">",
"       'Comorbid serious bacterial infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Children of any age with unusual or severe course",
"      </strong>",
"      &ndash; CBC and chest radiograph may be warranted to evaluate secondary bacterial infection and other conditions in the differential diagnosis in infants and young children with an unusual or severe course (eg, failure to improve after two to five days, wheezing that persists for more than one week) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Clinical course'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H28\">",
"       'Differential diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Children of any age with severe disease",
"      </strong>",
"      &ndash; In infants and young children with severe disease, arterial or capillary blood gas measurements may be necessary to evaluate respiratory failure. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Respiratory failure'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H70680853\">",
"    <span class=\"h2\">",
"     Severity assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe bronchiolitis is indicated by",
"    <strong>",
"     persistently",
"    </strong>",
"    increased respiratory effort (tachypnea; nasal flaring; intercostal, subcostal, or suprasternal retractions; accessory muscle use; grunting), hypoxemia, apnea, or acute respiratory failure [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1,86\">",
"     1,86",
"    </a>",
"    ]. Repeated observations are necessary to adequately assess disease severity because examination findings may vary substantially over time. Infants and young children with severe disease usually require hospitalization for frequent observation as well as respiratory",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fluid support. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/19/27962?source=see_link&amp;anchor=H162664498#H162664498\">",
"     \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\", section on 'Indications for hospitalization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other factors that that have been associated with increased illness severity include toxic or ill appearance, oxygen saturation &lt;95 percent by pulse oximetry while breathing room air, respiratory rate &ge;70 breaths per minute, and atelectasis on chest radiograph [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/33,34,87\">",
"     33,34,87",
"    </a>",
"    ]. However, there is limited",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    conflicting evidence relating these clinical findings to clinical outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/1,33,34,53,57,88,89\">",
"     1,33,34,53,57,88,89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several scoring instruments have been developed to assess the clinical severity of bronchiolitis in research settings [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/90-94\">",
"     90-94",
"    </a>",
"    ]. The use of these measures in clinical practice is limited by substantial variability in severity assessment between observers [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/95,96\">",
"     95,96",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchiolitis must be distinguished from a variety of acute and chronic conditions that affect the respiratory tract, including recurrent viral-triggered wheezing or asthma, pneumonia, foreign body aspiration, chronic pulmonary disease, aspiration pneumonia, congenital heart disease, heart failure, and vascular ring [",
"    <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/9,45\">",
"     9,45",
"    </a>",
"    ]. Severe bronchiolitis also can unmask underlying airway obstruction that existed before the infection (eg, vascular ring). Clinical features (eg, lack of preceding upper respiratory tract symptoms, witnessed episode of choking, differential aeration, poor growth) may help to distinguish some of these conditions from bronchiolitis; for others, radiographic or laboratory studies may be necessary.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Recurrent viral-triggered wheezing or asthma",
"      </strong>",
"      &ndash; Viral-triggered asthma is a major consideration in the differential diagnosis of bronchiolitis in older infants and toddlers. A history of recurrent wheezing episodes and a family or personal history of asthma, eczema, and atopy help to support a diagnosis of asthma. However during the first episode of wheezing, it is difficult to distinguish bronchiolitis from asthma [",
"      <a class=\"abstract\" href=\"UTD.htm?15/44/16074/abstract/97\">",
"       97",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/15/2298?source=see_link\">",
"       \"Virus-induced wheezing and asthma: An overview\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/6/34920?source=see_link\">",
"       \"Wheezing phenotypes and prediction of asthma in young children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/45/30424?source=see_link\">",
"       \"Approach to wheezing in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Bacterial pneumonia",
"      </strong>",
"      &ndash; It can be difficult to distinguish bacterial pneumonia from bronchiolitis in young children because the symptoms and signs of both conditions are nonspecific; children with bacterial pneumonia may be more ill-appearing (eg, higher fever), but clinical features cannot reliably differentiate bacterial from viral lower respiratory tract infection (",
"      <a class=\"graphic graphic_table graphicRef52021 \" href=\"UTD.htm?22/2/22573\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=see_link&amp;anchor=H29#H29\">",
"       \"Clinical features and diagnosis of community-acquired pneumonia in children\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Chronic pulmonary disease",
"      </strong>",
"      &ndash; Chronic underlying pulmonary conditions should be suspected in children with prolonged or recurrent symptoms, such as recurrent wheezing, failure to thrive, recurrent aspiration, stridor, or recurrent respiratory infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/61/21464?source=see_link\">",
"       \"Assessment of stridor in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/47/30458?source=see_link\">",
"       \"Approach to the child with recurrent infections\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=see_link&amp;anchor=H11#H11\">",
"       \"Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years\", section on 'Etiology'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Children with underlying pulmonary disease may have a superimposed acute episode of bronchiolitis, and in some cases, the underlying disorder is unrecognized before the acute episode. The clinical course of bronchiolitis in children with underlying pulmonary disorders tends to be severe and may require prolonged hospitalization.",
"     </li>",
"     <li>",
"      <strong>",
"       Foreign body aspiration",
"      </strong>",
"      &ndash; Clinical features of foreign body aspiration may include a history of choking (not always present), focal monophonic wheezing, decreased air entry, or regional variation in aeration. A high index of suspicion should be maintained for foreign body aspiration so that definitive treatment can be provided. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/33/2585?source=see_link\">",
"       \"Airway foreign bodies in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Aspiration pneumonia",
"      </strong>",
"      &ndash; Aspiration pneumonia may occur secondary to gastroesophageal reflux disease",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      swallowing dysfunction. It also may occur as a complication of bronchiolitis; the risk of aspiration increases during active bronchiolitis and resolves weeks later as tachypnea and the work of breathing subside. Clinical features associated with aspiration may include coughing with feeds, weak suck reflex, cyanosis during feeding, and recurrent or chronic stridor. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/46/30441?source=see_link\">",
"       \"Gastroesophageal reflux in infants\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/46/38632?source=see_link\">",
"       \"Aspiration due to swallowing dysfunction in infants and children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Congenital heart disease",
"      </strong>",
"      &ndash; Associated clinical findings of congenital heart disease may include failure to thrive, poor peripheral perfusion, and abnormalities on cardiac examination (eg, pathologic heart murmur, abnormal second heart sound, gallop, rub, active precordium). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/7/12409?source=see_link\">",
"       \"Suspected heart disease in infants and children: Criteria for referral\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Children with underlying cardiac conditions may have a superimposed acute episode of bronchiolitis, and in some cases, the underlying disorder is unrecognized before the acute episode. The clinical course of bronchiolitis in children with underlying cardiac disorders tends to be severe and may require prolonged hospitalization.",
"     </li>",
"     <li>",
"      <strong>",
"       Heart failure",
"      </strong>",
"      &ndash; Associated clinical findings may include exercise intolerance, easy fatigue, hepatomegaly, shortness of breath, peripheral edema. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9466?source=see_link&amp;anchor=H23884780#H23884780\">",
"       \"Etiology and diagnosis of heart failure in infants and children\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Vascular rings",
"      </strong>",
"      &ndash; Although stridor is more common, children with vascular rings may also have wheezing (typically with pulmonary artery slings). Anterior bowing of the trachea in the lateral chest radiograph may be a clue, but other modalities (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      contrast esophagogram, bronchoscopy, magnetic resonance angiography) usually are necessary for definitive diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/5/27735?source=see_link&amp;anchor=H11#H11\">",
"       \"Vascular rings\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/10/39074?source=see_link\">",
"       \"Patient information: Bronchiolitis (and RSV) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/19/27958?source=see_link\">",
"       \"Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bronchiolitis is broadly defined as a clinical syndrome that occurs in children &lt;2 years of age and is characterized by upper respiratory symptoms (eg, rhinorrhea) followed by lower respiratory infection with inflammation, which results in wheezing and or crackles (rales). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bronchiolitis typically is caused by a viral infection. Respiratory syncytial virus is the most common cause followed by rhinovirus; less common causes include parainfluenza virus, human metapneumovirus, influenza virus, adenovirus, coronaviruses, and human bocavirus. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Microbiology'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link\">",
"       \"Respiratory syncytial virus infection: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bronchiolitis typically affects infants and children younger than two years, principally during the fall and winter. Risk factors for severe disease",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      complications include gestational age &lt;37 weeks, age &lt;12 weeks, chronic pulmonary disease, congenital and anatomic defects of the airways, congenital heart disease, immunodeficiency, and neurologic disease. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H70682711\">",
"       'Risk factors for severe disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bronchiolitis is diagnosed clinically. Characteristic features include a viral upper respiratory prodrome followed by increased respiratory effort (eg, tachypnea, nasal flaring, chest retractions) and wheezing",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      rales in children younger than two years. (See",
"      <a class=\"local\" href=\"#H58735788\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Examination'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H25\">",
"       'Clinical diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chest radiographs and laboratory tests are not routinely indicated in the evaluation of infants and young children with suspected bronchiolitis, but they may be necessary to evaluate the possibility of comorbid or secondary bacterial infection, to help with management decisions (eg, initiation or continuation of antibiotic or anti-influenza therapy), or to evaluate conditions in the differential diagnosis. (See",
"      <a class=\"local\" href=\"#H58728348\">",
"       'Chest radiograph'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H317309641\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Severe bronchiolitis is indicated by",
"      <strong>",
"       persistently",
"      </strong>",
"      increased respiratory effort (tachypnea; nasal flaring; intercostal, subcostal, or suprasternal retractions; accessory muscle use; grunting), hypoxemia, apnea, or acute respiratory failure. Children with severe disease usually require hospitalization for respiratory and fluid support. (See",
"      <a class=\"local\" href=\"#H70680853\">",
"       'Severity assessment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/19/27962?source=see_link&amp;anchor=H162664498#H162664498\">",
"       \"Bronchiolitis in infants and children: Treatment; outcome; and prevention\", section on 'Indications for hospitalization'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The differential diagnosis of bronchiolitis includes recurrent viral-triggered wheezing or asthma, pneumonia, foreign body aspiration, chronic pulmonary disease, aspiration pneumonia, congenital heart disease, heart failure, and vascular ring. Clinical features (eg, lack of preceding upper respiratory tract symptoms, witnessed episode of choking, differential aeration, poor growth) may help to distinguish some of these conditions from bronchiolitis; for others, radiographic or laboratory studies may be necessary. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/1\">",
"      American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006; 118:1774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/2\">",
"      Bordley WC, Viswanathan M, King VJ, et al. Diagnosis and testing in bronchiolitis: a systematic review. Arch Pediatr Adolesc Med 2004; 158:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/3\">",
"      Fitzgerald DA, Kilham HA. Bronchiolitis: assessment and evidence-based management. Med J Aust 2004; 180:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/4\">",
"      Wainwright C, Altamirano L, Cheney M, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003; 349:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/5\">",
"      Plint AC, Johnson DW, Patel H, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med 2009; 360:2079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/6\">",
"      Colby TV. Bronchiolitis. Pathologic considerations. Am J Clin Pathol 1998; 109:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/7\">",
"      Aherne W, Bird T, Court SD, et al. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970; 23:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/8\">",
"      Wohl ME, Chernick V. State of the art: bronchiolitis. Am Rev Respir Dis 1978; 118:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/9\">",
"      Coffin SE. Bronchiolitis: in-patient focus. Pediatr Clin North Am 2005; 52:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/10\">",
"      Mansbach JM, Piedra PA, Teach SJ, et al. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med 2012; 166:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/11\">",
"      Mansbach JM, McAdam AJ, Clark S, et al. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med 2008; 15:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/12\">",
"      Midulla F, Scagnolari C, Bonci E, et al. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child 2010; 95:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/13\">",
"      Allander T, Tammi MT, Eriksson M, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A 2005; 102:12891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/14\">",
"      Calvo C, Garc&iacute;a-Garc&iacute;a ML, Pozo F, et al. Clinical characteristics of human bocavirus infections compared with other respiratory viruses in Spanish children. Pediatr Infect Dis J 2008; 27:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/15\">",
"      Richard N, Komurian-Pradel F, Javouhey E, et al. The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J 2008; 27:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/16\">",
"      Stempel HE, Martin ET, Kuypers J, et al. Multiple viral respiratory pathogens in children with bronchiolitis. Acta Paediatr 2009; 98:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/17\">",
"      Miron D, Srugo I, Kra-Oz Z, et al. Sole pathogen in acute bronchiolitis: is there a role for other organisms apart from respiratory syncytial virus? Pediatr Infect Dis J 2010; 29:e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/18\">",
"      Piotrowska Z, V&aacute;zquez M, Shapiro ED, et al. Rhinoviruses are a major cause of wheezing and hospitalization in children less than 2 years of age. Pediatr Infect Dis J 2009; 28:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/19\">",
"      Jacques J, Bouscambert-Duchamp M, Moret H, et al. Association of respiratory picornaviruses with acute bronchiolitis in French infants. J Clin Virol 2006; 35:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/20\">",
"      Counihan ME, Shay DK, Holman RC, et al. Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States. Pediatr Infect Dis J 2001; 20:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/21\">",
"      Greensill J, McNamara PS, Dove W, et al. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis 2003; 9:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/22\">",
"      Edwards KM, Zhu Y, Griffin MR, et al. Burden of human metapneumovirus infection in young children. N Engl J Med 2013; 368:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/23\">",
"      Kuypers J, Martin ET, Heugel J, et al. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics 2007; 119:e70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/24\">",
"      Kristoffersen AW, Nordb&oslash; SA, Rognlien AG, et al. Coronavirus causes lower respiratory tract infections less frequently than RSV in hospitalized Norwegian children. Pediatr Infect Dis J 2011; 30:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/25\">",
"      Lau SK, Woo PC, Li KS, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A 2005; 102:14040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/26\">",
"      Arnold JC, Singh KK, Spector SA, Sawyer MH. Human bocavirus: prevalence and clinical spectrum at a children's hospital. Clin Infect Dis 2006; 43:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/27\">",
"      Allander T, Jartti T, Gupta S, et al. Human bocavirus and acute wheezing in children. Clin Infect Dis 2007; 44:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/28\">",
"      Regamey N, Frey U, Deffernez C, et al. Isolation of human bocavirus from Swiss infants with respiratory infections. Pediatr Infect Dis J 2007; 26:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/29\">",
"      Kapoor A, Simmonds P, Slikas E, et al. Human bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections. J Infect Dis 2010; 201:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/30\">",
"      Mansbach JM, Pelletier AJ, Camargo CA Jr. US outpatient office visits for bronchiolitis, 1993-2004. Ambul Pediatr 2007; 7:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/31\">",
"      Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/32\">",
"      Pelletier AJ, Mansbach JM, Camargo CA Jr. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics 2006; 118:2418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/33\">",
"      Shaw KN, Bell LM, Sherman NH. Outpatient assessment of infants with bronchiolitis. Am J Dis Child 1991; 145:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/34\">",
"      Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995; 126:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/35\">",
"      MacDonald NE, Hall CB, Suffin SC, et al. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982; 307:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/36\">",
"      Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986; 315:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/37\">",
"      Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J 2003; 22:S40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/38\">",
"      Mansbach JM, Piedra PA, Stevenson MD, et al. Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation. Pediatrics 2012; 130:e492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/39\">",
"      Holman RC, Curns AT, Cheek JE, et al. Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics 2004; 114:e437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/40\">",
"      McConnochie KM, Roghmann KJ. Parental smoking, presence of older siblings, and family history of asthma increase risk of bronchiolitis. Am J Dis Child 1986; 140:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/41\">",
"      Figueras-Aloy J, Carbonell-Estrany X, Quero J, IRIS Study Group. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J 2004; 23:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/42\">",
"      Choudhuri JA, Ogden LG, Ruttenber AJ, et al. Effect of altitude on hospitalizations for respiratory syncytial virus infection. Pediatrics 2006; 117:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/43\">",
"      Turcios NL. Gauging the severity of bronchiolitis. J Respir Dis 1994; 15:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/44\">",
"      Lina B, Valette M, Foray S, et al. Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995. J Clin Microbiol 1996; 34:3007.",
"     </a>",
"    </li>",
"    <li>",
"     Welliver RC. Bronchiolitis and infectious asthma. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 6th ed, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/46\">",
"      Shazberg G, Revel-Vilk S, Shoseyov D, et al. The clinical course of bronchiolitis associated with acute otitis media. Arch Dis Child 2000; 83:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/47\">",
"      Andrade MA, Hoberman A, Glustein J, et al. Acute otitis media in children with bronchiolitis. Pediatrics 1998; 101:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/48\">",
"      Kuppermann N, Bank DE, Walton EA, et al. Risks for bacteremia and urinary tract infections in young febrile children with bronchiolitis. Arch Pediatr Adolesc Med 1997; 151:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/49\">",
"      Levine DA, Platt SL, Dayan PS, et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics 2004; 113:1728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/50\">",
"      Bilavsky E, Shouval DS, Yarden-Bilavsky H, et al. A prospective study of the risk for serious bacterial infections in hospitalized febrile infants with or without bronchiolitis. Pediatr Infect Dis J 2008; 27:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/51\">",
"      Ralston S, Hill V, Waters A. Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis: a systematic review. Arch Pediatr Adolesc Med 2011; 165:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/52\">",
"      Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children. Lancet 1998; 351:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/53\">",
"      Dawson KP, Long A, Kennedy J, Mogridge N. The chest radiograph in acute bronchiolitis. J Paediatr Child Health 1990; 26:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/54\">",
"      Swingler GH, Hussey GD, Zwarenstein M. Duration of illness in ambulatory children diagnosed with bronchiolitis. Arch Pediatr Adolesc Med 2000; 154:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/55\">",
"      Patel H, Gouin S, Platt RW. Randomized, double-blind, placebo-controlled trial of oral albuterol in infants with mild-to-moderate acute viral bronchiolitis. J Pediatr 2003; 142:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/56\">",
"      Petruzella FD, Gorelick MH. Duration of illness in infants with bronchiolitis evaluated in the emergency department. Pediatrics 2010; 126:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/57\">",
"      McMillan JA, Tristram DA, Weiner LB, et al. Prediction of the duration of hospitalization in patients with respiratory syncytial virus infection: use of clinical parameters. Pediatrics 1988; 81:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/58\">",
"      Green M, Brayer AF, Schenkman KA, Wald ER. Duration of hospitalization in previously well infants with respiratory syncytial virus infection. Pediatr Infect Dis J 1989; 8:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/59\">",
"      Dawson KP, Mogridge N. Acute bronchiolitis: a three year study. N Z Med J 1989; 102:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/60\">",
"      Robbins JM, Kotagal UR, Kini NM, et al. At-home recovery following hospitalization for bronchiolitis. Ambul Pediatr 2006; 6:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/61\">",
"      Wright PF, Gruber WC, Peters M, et al. Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. J Infect Dis 2002; 185:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/62\">",
"      Willson DF, Landrigan CP, Horn SD, Smout RJ. Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr 2003; 143:S142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/63\">",
"      Pinnington LL, Smith CM, Ellis RE, Morton RE. Feeding efficiency and respiratory integration in infants with acute viral bronchiolitis. J Pediatr 2000; 137:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/64\">",
"      Kneyber MC, Brandenburg AH, de Groot R, et al. Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr 1998; 157:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/65\">",
"      Bruhn FW, Mokrohisky ST, McIntosh K. Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr 1977; 90:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/66\">",
"      Hall CB, Kopelman AE, Douglas RG Jr, et al. Neonatal respiratory syncytial virus infection. N Engl J Med 1979; 300:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/67\">",
"      Willwerth BM, Harper MB, Greenes DS. Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med 2006; 48:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/68\">",
"      Ralston S, Hill V. Incidence of apnea in infants hospitalized with respiratory syncytial virus bronchiolitis: a systematic review. J Pediatr 2009; 155:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/69\">",
"      Hall CB, Powell KR, Schnabel KC, et al. Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. J Pediatr 1988; 113:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/70\">",
"      Thorburn K, Harigopal S, Reddy V, et al. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 2006; 61:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/71\">",
"      Duttweiler L, Nadal D, Frey B. Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis. Arch Dis Child 2004; 89:1155.",
"     </a>",
"    </li>",
"    <li>",
"     Viswanthan M, King V, Bordley C, et al. Management of bronchiolitis in infants and children. Evidence Report/Technology Assessment No. 69. ARHQ Publication No. 03-E014, Agency for Healthcare Research and Quality; US Department for Health and Human Services, Rockville, MD 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/73\">",
"      Schuh S, Lalani A, Allen U, et al. Evaluation of the utility of radiography in acute bronchiolitis. J Pediatr 2007; 150:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/74\">",
"      Harris JA, Huskins WC, Langley JM, et al. Health care epidemiology perspective on the October 2006 recommendations of the Subcommittee on Diagnosis and Management of Bronchiolitis. Pediatrics 2007; 120:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/75\">",
"      Antonow JA, Byington CL. Use of respiratory syncytial virus testing could safely eliminate many sepsis evaluations. Arch Pediatr Adolesc Med 1999; 153:1310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/76\">",
"      Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006; 368:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/77\">",
"      Hall CB. Diagnosis and testing in bronchiolitis: a systematic review. J Pediatr 2004; 145:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/78\">",
"      Vogel AM, Lennon DR, Harding JE, et al. Variations in bronchiolitis management between five New Zealand hospitals: can we do better? J Paediatr Child Health 2003; 39:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/79\">",
"      Adcock PM, Stout GG, Hauck MA, Marshall GS. Effect of rapid viral diagnosis on the management of children hospitalized with lower respiratory tract infection. Pediatr Infect Dis J 1997; 16:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/80\">",
"      Doan QH, Kissoon N, Dobson S, et al. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. J Pediatr 2009; 154:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/81\">",
"      Bourke T, Shields M. Bronchiolitis. Clin Evid (Online) 2011; 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/82\">",
"      Ahluwalia G, Embree J, McNicol P, et al. Comparison of nasopharyngeal aspirate and nasopharyngeal swab specimens for respiratory syncytial virus diagnosis by cell culture, indirect immunofluorescence assay, and enzyme-linked immunosorbent assay. J Clin Microbiol 1987; 25:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/83\">",
"      Macfarlane P, Denham J, Assous J, Hughes C. RSV testing in bronchiolitis: which nasal sampling method is best? Arch Dis Child 2005; 90:634.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Respiratory syncytial virus. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK.  (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.609.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/85\">",
"      Purcell K, Fergie J. Lack of usefulness of an abnormal white blood cell count for predicting a concurrent serious bacterial infection in infants and young children hospitalized with respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J 2007; 26:311.",
"     </a>",
"    </li>",
"    <li>",
"     Scottish Intercollegiate Guidelines Network. Bronchiolitis in children. A national clinical guideline. 2006. file://www.sign.ac.uk/pdf/sign91.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/87\">",
"      Mulholland EK, Olinsky A, Shann FA. Clinical findings and severity of acute bronchiolitis. Lancet 1990; 335:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/88\">",
"      Brooks AM, McBride JT, McConnochie KM, et al. Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics 1999; 104:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/89\">",
"      Roback MG, Baskin MN. Failure of oxygen saturation and clinical assessment to predict which patients with bronchiolitis discharged from the emergency department will return requiring admission. Pediatr Emerg Care 1997; 13:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/90\">",
"      Walsh EE, McConnochie KM, Long CE, Hall CB. Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis 1997; 175:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/91\">",
"      Martinello RA, Chen MD, Weibel C, Kahn JS. Correlation between respiratory syncytial virus genotype and severity of illness. J Infect Dis 2002; 186:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/92\">",
"      Klassen TP, Rowe PC, Sutcliffe T, et al. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr 1991; 118:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/93\">",
"      Groothuis JR, Woodin KA, Katz R, et al. Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr 1990; 117:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/94\">",
"      Englund JA, Piedra PA, Ahn YM, et al. High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J Pediatr 1994; 125:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/95\">",
"      Wang EE, Law BJ, Stephens D, et al. Study of interobserver reliability in clinical assessment of RSV lower respiratory illness: a Pediatric Investigators Collaborative Network for Infections in Canada (PICNIC) study. Pediatr Pulmonol 1996; 22:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/96\">",
"      Willson DF, Horn SD, Hendley JO, et al. Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness. Pediatrics 2001; 108:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/44/16074/abstract/97\">",
"      Landau LI. Bronchiolitis and asthma: are they related? Thorax 1994; 49:293.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6018 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-FDE34C00CC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16074=[""].join("\n");
var outline_f15_44_16074=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H70679837\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H70682711\">",
"      RISK FACTORS FOR SEVERE DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H58735788\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H317309589\">",
"      Comorbid serious bacterial infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H155909997\">",
"      RADIOGRAPHIC FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CLINICAL COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H70684147\">",
"      Dehydration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Apnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Respiratory failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Secondary bacterial infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Clinical diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H58728348\">",
"      Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H317309641\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Virologic studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H70680187\">",
"      - Other laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H70680853\">",
"      Severity assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6018\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6018|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/17/12561\" title=\"diagnostic image 1\">",
"      Bronchiolitis radiograph",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6018|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/5/13404\" title=\"table 1\">",
"      Pediatric signs of dehydration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/2/22573\" title=\"table 2\">",
"      Etiologic clues to pediatric pneumonia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/33/2585?source=related_link\">",
"      Airway foreign bodies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26746?source=related_link\">",
"      Antiviral drugs for the prevention and treatment of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/47/30458?source=related_link\">",
"      Approach to the child with recurrent infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/45/30424?source=related_link\">",
"      Approach to wheezing in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/46/38632?source=related_link\">",
"      Aspiration due to swallowing dysfunction in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/61/21464?source=related_link\">",
"      Assessment of stridor in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/19/27962?source=related_link\">",
"      Bronchiolitis in infants and children: Treatment; outcome; and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3607?source=related_link\">",
"      Clinical assessment and diagnosis of hypovolemia (dehydration) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=related_link\">",
"      Clinical features and diagnosis of community-acquired pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24346?source=related_link\">",
"      Clinical features and diagnosis of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/13/41176?source=related_link\">",
"      Coronaviruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28951?source=related_link\">",
"      Definition and etiology of fever in neonates and infants (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/61/7130?source=related_link\">",
"      Emergent evaluation of acute respiratory compromise in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=related_link\">",
"      Epidemiology and clinical manifestations of adenovirus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19383?source=related_link\">",
"      Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9466?source=related_link\">",
"      Etiology and diagnosis of heart failure in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=related_link\">",
"      Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=related_link\">",
"      Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/46/30441?source=related_link\">",
"      Gastroesophageal reflux in infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33304?source=related_link\">",
"      Human metapneumovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6713?source=related_link\">",
"      Mycoplasma pneumoniae infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36808?source=related_link\">",
"      Parainfluenza viruses in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/10/39074?source=related_link\">",
"      Patient information: Bronchiolitis (and RSV) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/19/27958?source=related_link\">",
"      Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=related_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=related_link\">",
"      Respiratory syncytial virus infection: Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/27/38327?source=related_link\">",
"      Respiratory syncytial virus infection: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/7/12409?source=related_link\">",
"      Suspected heart disease in infants and children: Criteria for referral",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/5/27735?source=related_link\">",
"      Vascular rings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/15/2298?source=related_link\">",
"      Virus-induced wheezing and asthma: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/6/34920?source=related_link\">",
"      Wheezing phenotypes and prediction of asthma in young children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_44_16075="Causes of noncompliance";
var content_f15_44_16075=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F76642&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F76642&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Factors that reduce compliance to antihypertensive therapy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Patient and disease characteristics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asymptomatic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic condition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Condition suppressed, not cured",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No immediate consequences of stopping therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Social isolation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Disrupted home situation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psychiatric illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Treatment characteristics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Long duration of therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complicated regimens",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Expensive medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Side effects of medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple behavioral modifications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lack of specific appointment times",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Long waiting time in office",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16075=[""].join("\n");
var outline_f15_44_16075=null;
var title_f15_44_16076="Oral medications for pediatric hypertensive urgencies";
var content_f15_44_16076=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Oral drugs for treatment of hypertensive urgencies in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Route*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Onset of action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration of action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mechanism of action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clonidine&bull;",
"       </td>",
"       <td>",
"        Oral",
"       </td>",
"       <td>",
"        0.05-0.1 mg/dose every hour up to 0.8 mg total dose",
"       </td>",
"       <td>",
"        15-30 minutes",
"       </td>",
"       <td>",
"        6-8 hours",
"       </td>",
"       <td>",
"        Central alpha2 adrenergic and imidazoline agonist",
"       </td>",
"       <td>",
"        Effective dose for acute hypertension in infants and toddlers is",
"        <strong>",
"         not",
"        </strong>",
"        known",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydralazine",
"       </td>",
"       <td>",
"        Oral",
"       </td>",
"       <td>",
"        0.25 mg/kg per dose up to 25 mg maximum single dose",
"       </td>",
"       <td>",
"        30 min",
"       </td>",
"       <td>",
"        2-8 hours",
"       </td>",
"       <td>",
"        Direct vasodilator",
"       </td>",
"       <td>",
"        Variable response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Isradipine",
"       </td>",
"       <td>",
"        Oral",
"       </td>",
"       <td>",
"        0.05-0.1 mg/kg per dose up to 5 mg maximum single dose",
"       </td>",
"       <td>",
"        &lt;1 hour",
"       </td>",
"       <td>",
"        6-8 hours",
"       </td>",
"       <td>",
"        Calcium channel blocker",
"       </td>",
"       <td>",
"        Stable oral suspension can be compounded",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Minoxidil",
"       </td>",
"       <td>",
"        Oral",
"       </td>",
"       <td>",
"        0.1-0.2 mg/kg per dose up to 10 mg maximum single dose",
"       </td>",
"       <td>",
"        1 hour",
"       </td>",
"       <td>",
"        8-12 hours",
"       </td>",
"       <td>",
"        Direct arterial vasodilator",
"       </td>",
"       <td>",
"        Most potent oral vasodilator with longest duration of action",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * All of this drugs can be compounded to make liquid formulations although stability will vary.",
"     <br>",
"      &bull; This dosing regimen is for older children and adolescents.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Flynn, JT, Tullus, K. Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol 2009; 24: 1101.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16076=[""].join("\n");
var outline_f15_44_16076=null;
var title_f15_44_16077="HRT and hip fracture WHI";
var content_f15_44_16077=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F55425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F55425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Estrogen-progestin therapy reduces hip fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 219px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the Women's Health Initiative, combined estrogen-progestin replacement therapy was associated with significant reduction in hip fracture (five fewer hip fractures per 10,000 person-years, HR 0.7, unadjusted 95% CI 0.4 to 1.0).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Rossouw JE, Anderson GL, Prentice RL, et al.&nbsp;Risks and benefits of estrogen and progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16077=[""].join("\n");
var outline_f15_44_16077=null;
var title_f15_44_16078="Troponin predicts outcome in unstable angina";
var content_f15_44_16078=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F57088&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F57088&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cardiac troponins are predictive of outcome in unstable angina",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 434px; height: 256px; background-image: url(data:image/gif;base64,R0lGODlhsgEAAfcAAP///4CAgAAAAICZ//+AgICzmeaAgMDAwEBAQKCgoPDw8BAQEDAwMFBQUCAgINDQ0HBwcODg4ABmM2BgYMwAAAAz//8AALCwsJCQkPLAwMDN///AwECMZsDZzc8QEPzw8PbQ0PD28xBwQEBm/9lAQP9AQFCWc99gYNYwMDCDWeJwcKDGs+ygoPng4GCggLDQwNxQUNDj2eDs5tIgIOmQkGCA/5C8pu+wsP/g4DBZ/+Dm//9gYHCpjSB5TbDA//+wsP+goHCN/9DZ///Q0FBz/yBN//8gIP8QEJCm//9wcKCz/xBA//9QUP/w8P8wMPDz/78AAP+QkH8AAL8GA6UAAEwAAJUwMLIAACYAANyQkAAGAz8MBubGwwBSKZkZDH8mE288Ng8v7wBfL49QUIBAQKkQEKUTCamQkGyZfJkAAFkAAG9Jr3IsFsUgIDwwMD8Wb4wAALajmcagoAAMBt9mgLmgoEBGQyBySd+goK3AsMmwsHlgYK2goFMgIFxQUEw/H5aWg7xwcCBmQ4aMdjMAAOKwsHUQECwgIAxSKT8MPxwQENJgYCAmI4gwMMxAQK+AvwATCXIAAM9QUAA/H7+MvwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAACyAQABAAj/AAEIHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmypMmTKFOqXMmypcuXMGPKnEmzps2bOHPq3Mmzp8+fQIMKHUq0qNGjSJMqXcq0qdOnUKNKnUq1qtWrWLNq3cq1q9evYMOKHUu2rNmzaNOqXcu2rdu3cOPKnUu3rt27ePPq3cu3r9+/gAMLHky4sOHDiBMrXsxYIo4NkCMfHFICCEnKlhtr9krAgufPBzdYIACy8wYAOAic3sxa6+MoFpxATv0jSQnSokkPpG1bN44dJXYMEfgjOAHSv0uUSNIERwkLO4Ck3jBENYANBIZvYLK8SevvTEWX/xAo2kKJIxaA5CZY/nx6HEecEDhyBMCP2ASMWLh+ewf0Ifo5kURuOFjABABMWIDDfUwkYSB4ECIlHnmj2TfaegOtdx8BsO1AwHMbPIcDAM8JBARw5gFg2nUVPtfEEeMleJx+EdZI1IQs4nZhhRlWmFtnHh7n3H4k7ufggCmuuB4Q0KVX5HHH2SglUDiulxuGFOqYXWw/bJDEEA4S8AONz/3A5HidqbZeE54d4R1sTGzwww5T1slTlT7uqFuWOdrnhGdO4NDEc0bQOAR6z42Hg35x8ugfnQLl59mBdlaKFQ7qARGfpZzGdeikw3Uq6qg9HfDAQAokEEACCgx0QQAYRP9A6qxaPRCAAAgMxACuAjAgEAS9LrCArLQWSxUCAuAq0AUCNABAAwJcoIAACwCAgQAQJLQBJQN06+234IYL7iNQlmvuueimq+667Lbr7rvwxivvvPTWay+UQHi32QHKAnBrAP4KEAC/uRI80AEBJJwwGYm8sYa4EEMcRBh03GvxxRhnrPHGHGd83g6rMWZwwAD/a/DIACCscAAIIADGFI1AcEBFQeRgbFCpFUrAiIqNfG22wGLwQK8AMOssQgkDwIUHUkCyAAIXTJRDEDcLtcEOMHb8bhQb6IvVA9cycIACEQjgwAEOCCBr2hdAm0BCSQPwAQpeIDKJFm9HpMMSQUT/DC4SGlQtUxNAaO0uikbc9kOoUyGbrAAzJ5C2A3k/sOsC2cINsEAfnIDCIF1oMYFEPvgNbg05VJBDDYAL3tUQP3yoX3AhrxX3QCp4AIgYjDTQqkgaIIG66jWYbvzxyCev/PLMN+/889B3i4QQPjWxAddu3T4QCxT8cYcdDPxeUvDRl2/++einrz7zNRRRwQgD+PCE6/5uXhAIHrBhwgQLnEq/UU8o3QgqUITire9vgROM9ggCAhR8AQ0JWEDU/pcUISDhgKdL3eqSl8Ds2c8gHyCBGfKAgVxRMC7kQ14H27JAg5xgCnFQ2wlnOJQWGoQGU9jCB2nIw53Y8IZUmEMB/0LQwyLm5IcG8QAWBNGDFxjxiTRBYkFUIIUJvKAHHJABFLfoEikSpAVQUAQAQlAACQyRi2hEiRcJQoIqTFAGHGhiGuc4kjVujwpHE8gLRFAAOvrRI3YciAcIIT4AxCAFHCDiH0eigUY6UgcHceQjRyKEESgBL4EUiAGkgIGChMAFPYjBIkVSgVKacgAHMeUpPzKACgROBwNYIV0yCYAWUMANB7GBCFYwSpA0MnWA04ES4kcEIlDvlxUI5kBg6YMgwE8gOqjBCGpAPQD4YJrdAkA0RzCCIDxBBwOsgRJgqQEhxBIAGhjAMYnQzfmphZYAgIEaiFWQDojABb0EyQATOP/AIqSuCAPZZ0E0UMoRLKEC41xCDgawhCVYU3UDcB864VeDClDTfVMj6AB0UAEiAIAIFdCBDzoahI7abocMucEVMmeQEKQgBYrM50YECoABCiR1AXXlQCuAypEOAAkWHcA+BwhJmwJACdJ8HwBaGTiN1rQCT1jCCD7K04hW4KQSmUEfFOICEXRApjPV6VMFYtSnytKpGm2lATdqVJuWNAgEnSpT0cnTo1oUoU/9FlYjssmZJWQFIrABWDNC07ZelaxiHQhaeSoE1flAA0EQQknjJ9EB+kAJSm1lLJ36hFIuYX5AJYIGfFCDvULElntYSAx64IKYDnYihT1sWWmq2Lr/OtUHqVOdDp7QT4kK4aADnKoO3CfaugKgoqUViFVN+k6UNuQEhijkQULAgRSI8rU3EaYGlKDQuKQqABNM2QHG61ekOZchGbhC3hZSAD6+oANaxK5MfltKY8JFAbvaVeYelyyFwHMgMxiDQ17AAw5wQAQSEIGBeeBE+Y7qZwBIm6ySRV6CqExhCDgvQ2gAB3pCRAYdeEF7TeBaB+PlAcRCcUdulS1kzSxZCGhAeVO2MpZpeCEfoMAZLhICE4igwSbGS4YFwrKOlA1XC4DcswIwAWp5uCD/HcgJrJCRPZI4yHV5AAIW4ICWPc0jtpKcAAriYs1VJANQ8B+PfQxkLMOF/1/8laBHEnAAaGXrAAxgMrWkS5AoDwQFgdiIlUvs5rZAYL0fSZYDNheBXfVKzQfxs0BYUAaO9JiPBci0pjfN6QKsIL6F5soDyGuqKN6YIR/wgB46QuBOu1rTPk4BD74a6qw4DsYGUTEAdG0SSQvkBIuISQd4kAIRmODVyE62spfN7GWvgNC1JoiqEiaATpJ5c0U+ia8BAAIo8LklMlhBs8dN7nIzu9guuG60E4KA0Q1Ey1z2sgl7feqGoCALgYlBV1Pw7HW/e7wX+PLB+Eut8JZk2wDAAxTkIJgQrADd6q71rQVmkEOzBOEAMAAV+EAYfYsgBeYud7//N+1VHUQBGP9QGKJJgvF4pmHlgHF4yMltAgmYYOSuK/VBJj7vg9fbIXOLxM8t5fCa3xzaonpAknvF516RF9IsH3pDWuCBKrjbdUW3+cy3vmmc08UBi4bAAq6uK6mv2OzohQIWyI51cXOd60b3OlyU7K+e/2rRCYO5SFo+EBpA4RBs97cnV2B0ZtsA1GFxgIwvwIDA81yNaH9uGxov+IXIfNk+Zu0LkI6VBDyuf7kmNdTrGHl7S4IB4at8RjpQgBRIAOS0FjWsnuyqAEQgAKPfe+lR7YEsoP7bqp9ICF4ASmMr2waxXwrKVV5xCjcg8LoHCQgoAIIJpD74G5GBDZQNytfzYAURL8r/4wsydrFlm94hYYEHWmB94GM/JCFgvY8lwIECvADxQHH6eEcPOQQcYAJ2R3oi4TkfYH25934lIQMixgEJdmwdwHk2kWcKgQAMoHjVBnkjQQInAAD8c4AIeBIxsALEJgGslXw2kTANgHcmVxBKlyzXh34i8QEzQAP+AnofKGzIpxMEh2sFEQGk5n4fwXcJgT83AAAR5IE3SBak9nQGwQDOogAOAH0L8V3h9V2s4l+7FxHqBwJGaINJuBZ0tiwGJxB0d34OgV+9gi0CsSvI4itmVhIGgAIfYIQCoHdfSBZDBgAQEIALYG0NkEcOAWESZjTPEi0HU2N5WBIwAAMCEUFA/3iHXQFn/AWIAtFkqFeHEcFiAOBi/0Iyh7gyiUgSc2MAAvF8kGgW8NZlMTZ6CtBkmCMRR7ZlkNOJnWheKIE/LAAACrAAM3aKYhGGCfEASMgQYZY21qKGQfOGJ3EDHsCFGOAAj+iLV2F7JbeCBNEyFkFndgYAZXM2EqaMJ0EDMzCHCMBS0ugV/cdfAch4FqFo9iNmlIOFK3ECJMCNvIhdlydKHbCP/Ih/ArECHBB+IBEDHMBLPDE2o8aEZKaOGKgSc7OBGOCGYBUDIqBgPSABHSABGrmRfWQQZWSCICEDBQCSOXEBtEcQe9gy5diQKkF1uSiBYMWADfYCMbCProd8iP8XAyZgYBgJADLgAhyQbgAgbh0QlEQkbtqnRQDJAYJlSEB5c07JATcnkrRmA1LZYJ5mla0VE22IezUhhBExfSAwNMOIRi7QgIc3EAxogjJQkQWwlm0JchUJAAzoAjxgc3SZYBh5lzxQc4f3egXgAiYgA4ApmBnZR3xZc06kkSlwkfgEExcwAWnTLLm2K2hjbTDIEur3AQEgkb30SRspAte1lgVhAxLASx9pmi7wlhjJgALhenmpSCLQA5lGfzFAgjxgAyFwmz2Qm/FnRgDwcWOEl/Q3nBwgEwpwAcgSgAwgLAewhyzJEp4DAAyAmaOkSEUJnHlpgh8JAB9ZRquZaXD/JAEC4ZquKRAkqGm89AIH9noAwJ4IlgKHCQDFSZ/HWZ/1+RLA0iyxYhDR4n9mGHUwgQIncADDkk9B+V6uR2ukSRAZaQLZ2QG3mQLvxQMEiZGmaQJ5ORA1N5JE6QLvVZEdAKL25FXAqZhlJFj4eZwwsZz9aRB9CDVRGJ0skWo0AJ29ZAOu93pA1qAEcZcf15MvsKMpMJ4XmUgbKhCfhGB8JANEGgNOypg1CZw9lmA8gJ4smp8v8QAQsCuUGDCP04sCCBP4UwgOYJ03eJ5cEQEJIJn9UhAl1ABjKKAxoX51sADR6G9quhWOU50nqQA6R6MuoQIo4Adfeo5VsSru53ku/5inGwGWF0ECjoA5NbYyEDCniEoVXBYAwCKFIAGpFjE3VlCpNbYADXCSmQoV96iHARh9NIE/NJgQCiB2aJqqUMGp4zUBMlaWGgGqF3EDMzADBjCHCIE2CMCrtpoTwmgtejdxPEinNpEBJOABKtACcENxyToUDAABt2KIBVGNeZeZNwECJ0ABJ8CFB6FlZ5OtQdF/TnioLeGrHNECuUMCGYAQGIA5jsquMBEt2BKgLyGvHfEBBhCsRWgQEdAAcsavOwEtdfiHphYUNNCMCBFwp8qwOZGwEKAAUBOxEusBxGoQs9qHGHsTwHgBmCoQD3CF2paFLkGACWGsyFqyJpGHOP96EPyyAAGwrxchsCKhgQtRizTrEpL4OPAqEAgTiq4qFHOjAguhrmI6tCeRii3TAKN3sin7qS77ErjIEPm6sVLLEsCIEDbbqlOoKhjwO0soj0UhlgyRsAsbtiixfOE6cAR3tAiBhsiCpwBAcGxbFFvYEBaLqnL7EeOnslumilYbEfziK2VGYeNlYYi4tTFBqCGrECNbq4WbaGKzfwYxthKBhhXobjAmY5ILipQbE/T4EDK7uSIBkwjxAA2gkubYEK3IZUy3ZK5IuD5rEg8JEULruh0BASoIc5P5rIFIcdDyQWVmi0lhoxABtcLbEYc7EJRJEZ4nNrtCZ3nmiu7Xuyf/AasR8bU8O70KkZCeWxANULsRIXZmAzCN5oJICL4nwQIzYK8QAbekao3ma7t7KLtzyj+0K6hIYQAeQALW+hAXwK2VCnYs278K4bD/96XVC61MQbDmerkUoZw6W75yW20AarYXl7o40QIn4AHDihEHsGW2B8EH8Z8r/KWzeqxySsBMAQLTmosYEQFNNgGEK7z8g7swJ8G6asNNkQEGmxE8LAATELXCqwDQ8or+WUJJa8ROYb/4ixEKEABP48QuTBAwHGNW7BQE6wEnkMAXscVdZodDS40rA3NBnDZsHIQkDBQfoAIUoAIaXBGSE4+bm46PE4BQTC3sO6Za0QIwgMJ7/4y9FbizcouQoiey8VrHQyGtM6DDGbHCHSy3FmctKEWBD9yyYAGsKHCvGvF/Y/fDmQqojTdes9t8ydLEY3wV6kcC6KrEPazKcwGoS/htK3kRWrZywXyQOwh9ybmcs3wVZXzGGxEBYud/fFG0FPbCIvwQtzcztzIz18wTt9dlCZO2uUa8sZzMWGHCFJDCGrHFXawXvAy5W5wAJTQBrfKmRAbPeTjDE+A/bdNuB3DNEYAsE5AA12wrM4Mwp1Jn5ejBH8FrO2c2EDCzvUrJS9EC0xqr6dzH+5vR+zvHWNFfZNgraTM69Ny3mAMtndScnTksntcAAcDS/IJ7abOtL102zv8CLRFgNMCCt1M7uy3DvhiQtYZsFpZsAERd1EZtACpwsA8Brhqt0Q6s0Ezh0X2bK9OSKyOtLFU9NNnCLBgQNib30gFT0BSHLLuYK8sbAMYIE46GvLV3exCNEfQLuCpw1HRNrYs8EhzsyFwh1f2iLFdtQrgC1mDNMskiMxSXzSlDcZ7XZG+DLCsTE3U4ZhOAUvtZZ55Kx3hB0ShwyyihyS2sFXwN2FZtd07XZJ3EZXUmAGAjMys92AIzXhQ3LXt2jIt32ScBOWdzswNRflUsynlhABRg0SnxALmcFaFNhqNdENSSZJljOWbzNhcwmb4D1hGQNjKGrT08EGidLDptEov/1mTXC8Yr/H/VDEgS7RUgMAMwcNckscT5rBYjXRXCCMW+YxAUaIGaGxJxXRUfkMimvBK3t85nEd9UEajpunQv6HN+oX5O2xLq3LGLhIYEbmFvnRH7fRUtgAIogMYrkSpg19QgzqlAbSfZu70g8V3grIuqEsoGceFYkTuY3BIJwMAhntGmCtWb0ZlreN66yIaz7eOe2eI8PhYZ4AHrjRRQHLedgtYJ480cLRGNu4mQQ4jQEl4XljBK6xf9PQOcXRQWi+OL0a0MyRGiO6O0iK00hrqFQQPnnBRJXuNwHudyHudPXhRXXrcbcbsxvcWHjeZCbhgNhMBJscBzXuiGbugo/63LZ3EtALO8EJaMzlsYd4zCdF3plk7USf0X/8fEXowW2YtnddiNaCNDkW4YNzDXl57qRu0BMc4XAZ5nh97pUOG+i9aIkzPHLp4X+LOBgcHUcS7rZZHreTE3R/7F4Dgq/S2Hxl7qs3LCXb7s9VM16qfq1J7qme6Lwt4Xp17t3E7X9/vsH5jtnVLGenyH4i4qiOwBwo2A5z4qGaDh//1+7U4qEwsDHK56804qk47O+D7kT4TDwtrtAj/wBF/wAh/vLOTvULTtBt/wDv/w3I7wbJHv0N4XFF9oIJABGq/x4J7xG58B4A4RONzqI49JCn+HJEABKq/y9WgQKb/yFNDyFf/RAgZwr8B9rzQv8XJx8W6W8eV6AiCfAQZwA/RYhD5vriBPEAbAAjRAAqQoNyqggeh6AzCggRmQ8xRtriyQ8yBQ8wAg9FyYAVVf7s1V8RnX5md/wCqfwMD99ARBAdQKA8ENACiAwnXfAtwDAwag9xlwzulNASigAn1vALbEiHLfAjdAATCAx4xY9hXf9ppEAfeKx6YM+QUR83IT89PntIlPA2yOAkv/9W1+86JPiimfavUo90Q9AxRgWstu+aRP+mfv9gOB+QAQ84Nf+hn38oI/+pKv+9xTrrmY8kbt+sYO+78v+5b/9qVcrjToATMg9tRHA4Kf97nf9hrf5jkG93P/yOYwkAFEb/xfjPw2//uzbxBw7wF5LBANRAGXDADAqvLrnfstwPrfj/Y/PxAFK//iDxAABA4kWNDgQYQJFS5k2NDhQ4gRJU6kWNHiRQokLm7k2NGjggMhQyoAIDKkwgABPK5k2dLlS5gxZQ7MONPmTYcHBOzceQAAz50oVeIkWtToUaRJlS6tCPJAgp0RfgoQSfBASqwIEGDl2tXrV7BhxY4lW9bsWbRp1a5l29btW7hxv/pkCnOCgAkCdyJoQFfgVbmBuWoVHJdwYbaHESfeujitYsePG4P1W5dlhKgCGwS4u0Cq5YUpQQsUXbe05dNKUzNdPVrm3bwFEVB1nbD1/9LbR3Mj3U20t9HftTvqFPD5AAPOAhaQFG4weNHnNqPfnB6z+szrzSXOhjAwAoOdDB5odz4UdPaX6GGqZ8nepXvy8T3Cb0m/o/355lXrZ81f/n+iThpNQKYIrMvApBBcSkEAG3TwQQgjlHBCCiu08EIMM9RwQw479PBDEEMUcUQSSzTxRBRTVHFFFltk0aTKEhxPIAUSCCAB5gKcsSSTjooAgwAwYK7GG3OU6ccgmYPRqAeAxJFGG590EUCgBFjqgQAEQGAg8GZjgCgstRyoyqNmC0+gLgX40iYz1dQLKKOA2hKANNecUr6eGCTKzDkvEKABABoQ4AKc+ByTKj1luv9AAQUcoMpPQAUldKZFG6UtzxhtSgAAzKyENNBB78RTy74KFBOALFVKNcBTp+IrU6IcjWDVVXGS1dVSjToAAgFU7RXVX0Ulb7POPkvwVFqDvUmnOQNNzjOkMBCgu2T9g0na7pwt1qgEuAPWV2uFrW02WFmdE1sAeMXAXIPIPYrX2NBV9yZ426WtTKrkFWBdcYU77lkjmZSWgQMUwMyBA269qUk1C/63s4BtEtSBlA44OOHiJBaA4gBCQg7iAJHjtbiLFe7Xte/C2xGpNmlLwFEHNi0UKIvBU3NlnKpU6eWNZZ5J55RvLipoByblOeaTk1Z6aaabdvppqKOWemqqq7b/+mqss9Z6a6679vprsMMWe2yyyzb7bLTTVnttttt2+22445Z7brrrtvtuvPPWe2+++/b7b8DJ7nE9rShCIFuGusU5ocMDdzwioBbweSWoNtMpXNsmR+lehm58/POGgkrZp275IvSCAKSykVEICCMoggm0gsDg2SY44K6tAFAgANM57fiCyT2/6oLYJ70dgQnC9MlzVDd9IPYGNmX+ggYQ4NdG6htYHPS9gwKg8kAhCEBWqNZdwAEAHFggAAjQH+iArWB7wFEGEgDPgS0ZWB+8B3RaoNWfbClLCzBTBHSCnMZcak5awszHACUmSPGqO7NxwP24BzjvMct3CHBUwRbA/wA/mW8BE0hdQRIQOzFlySeXA8ADtJScjk3LICmkDa8OIKjPzEqBekGACx0AASEFEFQk0R8AZoMmK13Qb96DygQi8MET0uYu4CHJAxrgKGgJRIIaVGFJfsUsrIREWWMSIG1UeMSBdPFUEETA/74kJjQeMY5JVCLfepKABXhGJ31xF3EAZcQEwE8AO5oN8Gi4wj8RKo+BxEAgx8hDYC0vX3gBTBf/BwHc3e4CB8ijEKUVgE/NsY59A4r2BNIZ8NDFUZMSVM8I8oD/zaaMdJnNAlrYyqKxsCCHjCSqsIg6l+WRVwgImniEmK7/NYAkohzlKBWwsWZGE0WflGY1rXlNbD1mU5vb5GY3vflNcIZTnOMkZznNeU50plOd62RnO935TnjGU57zpGc97XlPfOZTn/vkZz/9+U+ABlSgzQwIADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among patients with class IIIB unstable angina (primary acute rest angina within the preceding 48 hours), both ST segment depression and serum troponins have independent predictive value. Serum troponins can distinguish between patients at high risk for a cardiac event at 30 days and those at low risk (20 percent if troponin-positive versus less than 2 percent if troponin-negative).",
"    <div class=\"footnotes\">",
"     TnI: troponin I; TnT: troponin T.",
"    </div>",
"    <div class=\"reference\">",
"     Data from Hamm CW, Braunwald E. Circulation 2000; 102:118.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16078=[""].join("\n");
var outline_f15_44_16078=null;
var title_f15_44_16079="Partial septate uterus";
var content_f15_44_16079=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60684&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60684&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Septate uterus: partial",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 354px; height: 223px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      Reproduced with permission from: Pediatric and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"     </p>",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_44_16079=[""].join("\n");
var outline_f15_44_16079=null;
